Every 2 minutes someone is diagnosed with lung cancer. Help us change that statistic.

Bookmark and Share
Lung Cancer in the News: 2013 PDF Print E-mail

 

January | February | March | April | May | June | July
| August | September | October | November | December

December

Week Ending December 29, 2013

Memorial Sloan-Kettering Research Featured in Report on Top Cancer Advances of 2013
Every December the American Society of Clinical Oncology (ASCO) publishes a report highlighting the major achievements in clinical cancer research over the previous year.

10 More New Reasons to Check Your Home for Radon
A few years back I came up with some "novel" reasons why everyone should check their home for radon. Hopefully these "10 new reasons" prompted at least a few people to pick up a radon test kit. Remember, it doesn't take any willpower, you can do it in your PJ's, and it's cheaper than therapy. Yet even though testing is easy, and knowing that radon-induced lung cancer is a largely preventable disease, too few families have checked their homes.

Working to end cancer, aided by technology, screening
Few words evoke as much dread or fear as “cancer.” New research and cutting-edge care are redefining what a cancer diagnosis means.

Cancer specialists now have more options in customizing a person’s care than ever before. While cancer is never a diagnosis anyone wants to receive, these medical advances are changing the face of living with cancer.

Graham offers early lung cancer detection screenings
Bob Senneff, President and CEO of Graham Health System, announced in November that Graham is now offering early detection lung cancer screenings with low-dose CT scans.

New marker identified for early diagnosis of lung cancer
A protein called isocitrate dehydrogenase (IDH1) is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

New laws: Radon information requirement included
ST. PAUL — A late central Minnesota woman’s wish for safer homes comes true when 2014 begins. Once Janet Thompson learned she had terminal lung cancer, her health battle joined with a fight to make sure Minnesotans knew about the danger of radon. Thompson, who lived in Glenwood, south of Alexandria, tried to talk people into checking their homes for radon, a colorless, odorless gas that can cause cancer.

With screening, new medical advances, lung cancer survivor rates are improving
“Lung cancer forms in the tissues of the lung, usually in the cells lining the air passages. There are two main types of lung cancer — small cell lung cancer and non-small cell lung cancer.”

MicroRNA-31 Might Predict Lung-Cancer Spread
COLUMBUS, Ohio – “Determining whether a patient’s lung cancer has spread to nearby lymph nodes is critical for identifying the most effective therapy, but it usually requires surgery. A new study suggests, however, that measuring levels of a particular molecule in a sample of tumor tissue might accurately answer the question.”

Clinical trial examines use of human immune system to fight aggressive lung cancer
“Researchers at the Cincinnati Cancer Center (CCC) and the UC Cancer Institute are conducting a clinical trial examining a method to stimulate the human immune system to destroy or block the growth of lung cancer cells.”

More research needed to establish tomo as lung screening tool
“Investigators in a recent study of digital tomosynthesis (DT) say the technology has the potential to become a viable alternative to lung cancer screening, but further research is needed to reach that conclusion.”

Northside introduces new cancer diagnosis technology
FORSYTH COUNTY, Ga. — “Northside Hospital-Forsyth's pulmonary and therapeutic endoscopy lab announced the addition of new technology in the diagnosis of lung cancer.”

Breathing uneasy
“Bai Yun (pseudonym) was shocked when she was diagnosed with lung cancer in 1999. A non-smoker whose family had no history of lung diseases, her cancer was most likely caused by inhaling secondhand smoke at her office where she worked as a secretary.”

Week Ending December 22, 2013

With screening, new medical advances, lung cancer survivor rates are improving
“Lung cancer forms in the tissues of the lung, usually in the cells lining the air passages. There are two main types of lung cancer — small cell lung cancer and non-small cell lung cancer.”

MicroRNA-31 Might Predict Lung-Cancer Spread
COLUMBUS, Ohio – “Determining whether a patient’s lung cancer has spread to nearby lymph nodes is critical for identifying the most effective therapy, but it usually requires surgery. A new study suggests, however, that measuring levels of a particular molecule in a sample of tumor tissue might accurately answer the question.”

Clinical trial examines use of human immune system to fight aggressive lung cancer
“Researchers at the Cincinnati Cancer Center (CCC) and the UC Cancer Institute are conducting a clinical trial examining a method to stimulate the human immune system to destroy or block the growth of lung cancer cells.”

More research needed to establish tomo as lung screening tool
“Investigators in a recent study of digital tomosynthesis (DT) say the technology has the potential to become a viable alternative to lung cancer screening, but further research is needed to reach that conclusion.”

Northside introduces new cancer diagnosis technology
FORSYTH COUNTY, Ga. — “Northside Hospital-Forsyth's pulmonary and therapeutic endoscopy lab announced the addition of new technology in the diagnosis of lung cancer.”

Breathing uneasy
“Bai Yun (pseudonym) was shocked when she was diagnosed with lung cancer in 1999. A non-smoker whose family had no history of lung diseases, her cancer was most likely caused by inhaling secondhand smoke at her office where she worked as a secretary.”

Week Ending December 15, 2013

Erlotinib ‘dose-to-rash’ strategy effective in advanced NSCLC
“Erlotinib as first-line therapy in patients with advanced non-small-cell lung cancer (NSCLC) is equivalent to chemotherapy with regard to overall survival, an “all-comers” phase II trial has shown.”

BUSM researchers identify molecule that could aid lung cancer detection, treatment
“Researchers at Boston University School of Medicine (BUSM) have discovered a molecule that could help lead to the non-invasive detection of lung cancer as well as its treatment. Using RNA sequencing, the team looked at airway epithelial cells and identified a regulatory molecule that was less abundant in people with lung cancer and inhibits lung cancer cell growth. The findings, which are published in the Proceedings of the National Academy of Sciences, suggest that this molecule may aid in diagnosing lung cancer in earlier stages and could potentially, when at healthy levels, aid in treating the disease.”

Lung cancer stigma hurts awareness, hampers research
CHICAGO – “November was Lung Cancer Awareness Month, but you’d never know it. Consumers aren’t bombarded by products in blue, the color designated by some to raise the profile of the disease. No NFL players or coaches wore blue-ribboned apparel, despite donning pink just a month earlier for breast cancer.”

Cetuximab fails in second-line combination for recurrent NSCLC
“Results from a phase III trial indicate that cetuximab should not be given alongside chemotherapy in patients with recurrent non-small-cell lung cancer (NSCLC) after platinum-based therapy.”

Lung cancer takes higher than expected toll in south suburbs
“A state report on cancer rates indicates that more people die from lung cancer than expected in some south suburbs, particularly among women.”

Hospital offers free lung cancer screening
“Northwestern Lake Forest Hospital has launched a new lung cancer screening program designed to detect the early stages of lung cancer in people who are at higher risk for the disease.”

Week Ending December 8, 2013

Cedar Hills honors lung cancer survivor
CEDAR HILLS – “A Cedar Hills resident who is terminally ill with stage IV lung cancer received honors as a community champion from her city last week.”

Groups raising radon awareness
OR – “West Salem parents anxiously awaiting the release of a report on a possible environmental cause for a string of childhood cancer cases there wonder — was radon responsible?”

Lung Cancer Detection Rate 'Boosted' By TV Ad
An advertising campaign may be re-run after it led to hundreds of people reportedly being diagnosed with lung cancer.

UK – “A Government TV campaign urging people with a three-week-old cough to visit the doctor has reportedly boosted lung cancer detection rates.

The Be Clear On Cancer advert ran between May and June last year to raise awareness of a range of cancers.”

Merck Serono Announces New Publication of Results of the Phase III START Trial Investigating Tecemotide in Non-Small Cell Lung Cancer in The Lancet Oncology
“Merck Serono, the biopharmaceutical division of Merck, today announced that The Lancet Oncology has published results from the Phase III trial of its investigational MUC1 antigen specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC), known as the START* trial.”

Nonsmokers with lung cancer have to battle stigma, too
Lung cancer is the leading cause of cancer death in the U.S., more than breast, prostate, colon and pancreatic cancers combined. Ten to 15 percent of people diagnosed each year were never smokers. But the stigma that it’s their fault haunts patients, support groups and even research funding.

CHICAGO — “November was Lung Cancer Awareness Month, but you’d never know it.”

Helping lung cancer patients beat insomnia
“UB gets NIH grant tofund study of cognitive behavior therapy delivered by bedside nurses

It is estimated that anywhere from 50 to 80 percent of persons diagnosed with lung cancer experience severe insomnia that may persist for an average of eight years after the initial diagnosis.”

Training advised to plug lung cancer care gaps
“Guideline-consistent care for patients with suspected lung cancer with mediastinal lymphadenopathy without distant metastases varies by region and physician characteristics, say researchers.”

Clinical Trial Examines Efficacy, Safety of Drug Combination for Lung Cancer
“Researchers at the University of Cincinnati Cancer Institute are looking for patients with lung cancer whose tumors test positive for the ALK gene to participate in a clinical trial examining the safety and efficacy of an experimental drug named AT13387 in combination with the standard therapy crizotinib.”

Developments in screening and surgery increase lung cancer survivors
“Richard Macdonnell began smoking when he was a high schooler. When he knew about low-measurements CT scans to diagnose lung growth, he knew he too should go in for it.”

A Miracle Drug Cured Ed Levitt of Stage IV Lung Cancer. Then the FDA Withdrew it From the Market.
“I have a new video out today (click above) that I made for the Manhattan Institute, which tells the story of Ed Levitt, who in 2004 was diagnosed with terminal lung cancer. Unable to get out of bed and covered in tumors from head to toe, Levitt's doctors advised him to start making funeral arrangements.”

Week Ending December 1, 2013

Seattle Cancer Care Alliance Leads Nation in Innovative Lung Cancer Treatment Options
Anti-PDL-1 and UW-OncoPlex are changing the future of lung cancer treatment

SEATTLE – “Lung cancer steals more lives each year than colorectal, breast and prostate cancers combined, according to the American Cancer Society. Seattle Cancer Care Alliance (SCCA) experts are dedicated to reducing this alarming statistic by developing and offering breakthrough diagnostic tests and treatment options to patients through clinical trials. Patients are currently benefitting from SCCA’s next- generation genetic testing and revolutionary immunotherapy treatments, leading to improved cure rates while decreasing damaging side effects from traditional treatments. Both anti-PDL-1 and UW-OncoPlex are changing the way doctors treat lung cancer, bringing renewed hope to patients fighting this challenging disease.”

Older Lung Cancer Patients Desire Information on Complementary Therapies
“Once considered "alternative" treatments, many cancer centers are now using complementary therapies as a regular part of cancer treatment. This integrative approach - combining conventional treatments such as chemotherapy and surgery with complementary treatments such as acupuncture - is designed to treat the whole person; body, mind and spirit.”

2 MD Anderson Researchers Among 16 Chosen For Lung Cancer Research Foundation’s 2013/2014 Research Grant Awards
“Two prominent lung cancer researchers from the University of Texas MD Anderson Cancer Center were recently chosen as two of just sixteen researchers nationwide to receive this year’s crop of $800,000 awards from the Lung Cancer Research Foundation. The announcement was made at the Foundation’s 8th Annual Lung Cancer Awareness Luncheon, which named Dr. Faye Johnson, MD, PhD and Dr. Jonathan Kurie, both of MD Anderson, among the recipients.”

Advances in screening, surgery help more survive lung cancer
TAMPA — “Richard Macdonnell started smoking when he was a teen. When he heard about low-dose CT scans to detect lung cancer, he knew he was a candidate.”

Diesel exhaust responsible for thousands of lung cancer deaths
“AN ESTIMATED SIX percent of lung-cancer deaths in the United States and the United Kingdom—11,000 deaths per year—may be due to diesel exhaust, according to a new study.”

Endobronchial ultrasound has edge for lung cancer staging
“Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a better primary procedure than endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for staging non-small-cell lung cancer, study results suggest.”

A cough could be 'lung cancer warning'
“People should take unexplained coughs and chest infections seriously, says an expert concerned about delays in the diagnosis of lung cancer.”

Florida lung cancer patient undergoes robotic surgery
Tampa, Florida – “It's the leading cause of death in the U.S., but lung cancer doesn't have to be a death sentence. In fact, surgeons are going high tech to tackle some of the worst cancers.”

Lung cancer survivor takes on Atlanta Half Marathon
ATLANTA – “Look around, and you'll find lots of reasons to be thankful. But Kristen Carlton's thank-you list is a long one this year, and you might be surprised to find that kidney stones are high atop that list.”

Surgeon hails new lung cancer screening protocol
“Dr. John Rea has been a physician for more than 40 years. While working at a research hospital while attending college, Rea found that he loved interacting with patients and helping them cope with terrifying and life-threatening illnesses.”

Former Falcon highlights the changing face of lung cancer
ATLANTA – “Former Atlanta Falcon Chris Draft is teaming up with cancer patients and survivors to bring more attention and resources to lung cancer, the deadliest type of cancer for both men and women.”

Lung cancer survivor advocates for radon testing
FOREST CITY – “Gail Orcutt's home nearly killed her. Orcutt, a retired teacher from Pleasant Hill, was diagnosed with lung cancer in 2010. She never smoked. Her husband never smoked. She didn't work in an environment where smoking was allowed and she wasn't in contact with asbestos.”

A Personal Loss Helps David Discover and Beat Lung Cancer
“Sometimes a tragic or sudden event happens that forces you to really look at your life and take action. This scenario came as a blessing in disguise for David Hanbidge as a personal loss helped him overcome lung cancer.”

November

November is Lung Cancer Awareness Month

As the month of November brings lung cancer into focus, it is time to honor all those living with the disease and remember those we have lost.

We are making progress! With new targeted therapies, early detection, and continued clinical trials, we are increasing survival times.

WE HAVE HOPE!

Take the time to raise awareness of the disease in your community.

Week Ending November 24, 2013

Local Lung Cancer Advocates Join Others From Across the Country to Host Candle Vigil
“Jessica Steinberg and Barbara Ferguson will host a lighted vigil at Town Center Park at 29800 SW Park Place in Wilsonville, Oregon with more than 100 attendees expected locally as part of a national campaign to raise awareness for lung cancer on November 19th at 7:00 PM; we will join more than 90 communities across the nation in hosting a Shine a Light on Lung Cancer Vigil in partnership with Lung Cancer Alliance, Caring Ambassadors Program, and Compass Oncology.”

Radon and Lung Cancer
ARRISONBURG, Va. (WHSV) – “Radon is the second leading cause of lung cancer behind smoking. But how do you know you aren't living in a contaminated home?

Dusty Donaldson, the executive director of the Dusty Joy Foundation, a local lung cancer advocacy group, explained why radon is common in the Valley.”

Lung cancer gene found in non-smokers
A gene that could help explain why some non-smokers develop lung cancer has been pinpointed by US researchers.

Study finds that no racial difference of people of same socioeconomic status
DENVER – “According to the American Cancer Society, an estimated 160,340 lung cancer deaths occurred in the United States in 2012, accounting for 28 percent of all cancer deaths. While survival from lung cancer has improved since the early 1990s, racial differences in lung cancer survival persist such that blacks experience poorer 5-year survival for lung cancer compared to whites.”

HMHP launches lung cancer screening program
YOUNGSTOWN, Ohio – “Of all of the people diagnosed with lung cancer each year, only one in eight are diagnosed in the early stage.

"The symptoms are really minimal and because of that it usually progresses to the time that people develop symptoms where it is quite advanced," said Dr. Timothy Barreiro with Humility of Mary Health Partners.”

Genes play a role in lung cancer
ISSISSAUGA — “Tamika Sutherland knew something was wrong when the usual five-minute walk from work to her Meadowvale home took over 45 minutes one day.”

Mayo Clinic researchers identify biomarker for smoker’s lung cancer
ROCHESTER, Minn. — “Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein — ASCL1 — is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET. The findings appear in the online issue of the journal Oncogene.”

Doctors Using Genetic Testing To Target Lung Cancer
COLUMBUS, Ohio - “The latest in cancer treatment might come from you -- your genes.”

Week Ending November 17, 2013

Why Is Lung Cancer Rising Among Nonsmoking Women?
One in five women with lung cancer has never smoked, and the diagnosis rate among women is only increasing

“For years when Rebecca Falzano was living in New York City, she woke up every morning wheezing and catching her breath. Her doctor told her she had asthma, but no inhaler fixed her difficult breathing.”

Huntsville man shares story of hope against lung cancer
HUNTSVILLE, AL (WAFF) – “November is Lung Cancer Awareness month, and a Huntsville man is hoping his story will save lives.”

Molecule noninvasively detects and treats lung cancer
“A molecule has been discovered that could lead to noninvasive detection and treatment of lung cancer. RNA sequencing was used to examine airway epithelial cells and to identify a regulatory molecule that is less abundant in people with lung cancer. This molecule inhibits lung cancer cell growth, and it may aid in diagnosing lung cancer in earlier stages and in treating the disease.”

Hospital Plans Lung Cancer Talk
DERBY — “In recognition of The Great American Smokeout and Griffin Hospital’s new Low-Dose CT Lung Cancer Screening Program, the hospital will host a free talk entitled Lung Cancer: Know Your Risks, Know Your Options at 6 p.m. on Tuesday, November 19, in the hospital’s Meditation and Learning Center, 130 Division St.”

Early detection vital with lung cancer
“State Representative Kim Rose (D-Milford), a lung cancer survivor and advocate, reminds residents that November is National Lung Cancer Awareness Month. Started in 1995, it has generated support across the country with events taking place during the month to educate people about this type of cancer. The State of Connecticut declared November as Lung Cancer Awareness Month in 2006.”

Tuesday forum to focus on lung cancer and screening recommendations
“Lung cancer’s impact on Kentucky will be discussed, along with proposed guidelines for screening, at a community forum Tuesday in Louisville.”

Edward Hospital’s CT lung scan can be a lifesaver
“While tobacco use remains the leading cause of lung cancer, a screening that includes low-dose computerized tomography (CT) may help smokers and ex-smokers breathe a little easier about the future.”

Lung cancer: Kick the habit — and get screened
“Year after year, lung cancer continues to be the No. 1 cause of cancer death in the U.S. and worldwide. This year, more than 228,190 people in the U.S. are expected to be diagnosed with lung cancer and approximately 160,000 people are expected to die from the disease — enough people to fill Dodger Stadium, Yankee Stadium and Chicago’s Soldier Field to overflowing.”

Man Cancer Free After Winning Lung Cancer Screening
“A year ago KATC and Our Lady of Lourdes teamed up to give away free CT lung cancer screenings. One of the winners, 59-year-old Dean Dugas, says the screening may have saved his life. Dugas was one of 40 people picked for a free screening, and got his done right away.”

Draft’s Defensive Team: Lung Cancer Awareness
“Almost nobody knows that November is Lung Cancer Awareness Month,” said Chris Draft, former linebacker for the Washington Redskins. “It’s not just a smoker’s disease. Anyone can get lung cancer.”

Lung cancer top killer, but lacks clout in research arena: oncologist
TORONTO – “Lung cancer kills more Canadians each year than any other malignancy, but the disease receives a disproportionate amount of research and donation dollars compared with far less deadly cancers, says a national advocacy organization.”

K.C. Oakley Looks to Beat Lung Cancer Big Time
“Since her best friend Jill Costello passed away in June 2010 to lung cancer, USST and T2 freestyle skier K.C. Oakley has vowed to “beat lung cancer big time.” Already recognized for her dedication to the cause by T2’s community service award in 2012, Oakley’s passion and outstanding service to beating lung cancer remains strong.”

Week Ending November 10, 2013

Early detection vital with lung cancer
“State Representative Kim Rose (D-Milford), a lung cancer survivor and advocate, reminds residents that November is National Lung Cancer Awareness Month. Started in 1995, it has generated support across the country with events taking place during the month to educate people about this type of cancer. The State of Connecticut declared November as Lung Cancer Awareness Month in 2006.”

Smoggy Beijing sees lung cancer cases soar
“The number of lung cancer cases in the Chinese capital Beijing has soared over the last decade.”

UPMC lung cancer researcher awarded grant
“Dr. Timothy F. Burns has a personal and professional stake in the fight against lung cancer.

Burns, 39, a medical oncologist at UPMC Cancer Center and an assistant professor of medicine at the University of Pittsburgh School of Medicine, lost his father to lung cancer when he was 7. Nine years later, his mother succumbed to the disease.”

Rethink pink, look at lung cancer
“My heart saddened on reading about Jennifer Downey, 46, who is a non-smoker with lung cancer. Seven years ago my daughter-in-law became pregnant and we were ecstatic with this news.”

Anyone Who Breathes Air Can Get Lung Cancer
“My patient, "Judy," is one of more than 228,000 Americans this year who will be diagnosed with lung cancer. And like most of her fellow lung cancer patients, she is struggling not only to learn all she can about her diagnosis and treatment options, but also to adjust to the overwhelming burden of shame and stigma that plagues this disease. When asked who is providing her with support, Judy said she is ashamed to admit her metastatic, incurable cancer diagnosis to loved ones, and that she is baring the burden alone. Because one of the strongest risk factors for lung cancer is smoking, our society has come to the conclusion that people diagnosed with lung cancer somehow deserve it, that it was brought on by their own "bad" behavior.”

Other Views: Too many people believe myths about lung cancer
“November is National Lung Cancer Awareness Month. It provides 30 full days to devote toward education about the disease, raise lung cancer’s profile throughout the country and provide an opportunity to share misconstrued yet important facts about lung cancer.”

Genotyping Lung Cancer Linked to Better Survival
“Genetic testing for personalized treatment of lung cancer was associated with improved survival, likely due to getting targeted kinase inhibitors to the right patients, a study showed.”

Week Ending November 3, 2013

Research study aims to understand inherited lung cancer gene
“A new research study, funded by the Bonnie J. Addario Lung Cancer Foundation (ALCF), is aiming to understand how an inherited gene in some lung cancer patients could serve as an early detection screening for family members.”

Stigma lingers for deadliest cancer
(CNN) – “My patient, "Judy," is one of more than 228,000 Americans this year who will be diagnosed with lung cancer.”

Franciscan Alliance hospitals offer lung cancer screenings that can help save lives
“Franciscan Alliance has expanded its war on lung cancer, the leading cause of cancer deaths in the U.S., through a potentially life-saving screening initiative that can uncover problems and lead to treatment.”

CTCA doctor presents studies at World Conference on Lung Cancer in Australia
“Glen J. Weiss, MD, Director of Clinical Research, Cancer Treatment Centers of America® (CTCA) is presenting two key studies, including one today at the International Association for the Study of Lung Cancer's (IASLC) 15th World Conference on Lung Cancer being held in Sydney, Australia.”

Former Redskin Chris Draft and Marine fight lung cancer
LANDOVER, Md. (WJLA) – “Smiling and surrounded by his family at the Redskins game on Sunday, you’d never know Marine Corps Major Joe Newcomb is fighting for his life.”

Genetic testing could 'improve lung cancer survival'
“Survival rates for patients that are diagnosed with lung cancer could be vastly improved by genetic testing, according to a new study. Research, published in the journal 'Science Translational Medicine', has found that the genetic profiling of lung tumours helped to improve survival rates of patients.”

Experimental drug shows encouraging results in treating most common form of lung cancer
“Los Angeles, California - An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death among men and women worldwide.”

Lung Cancer Screening is Topic of Community Forum
BOWLING GREEN, Ky. (10/30/13) – “A community forum will be held November 6, at the WKU Health Sciences Complex, 700 First Avenue, Bowling Green, KY to discuss lung cancer – Kentucky’s most deadly cancer.”

Northwest Community Healthcare Offers Early Lung Cancer Screening at Reduced Rate
“In honor of Lung Cancer Awareness Month in November, Northwest Community Healthcare (NCH) is offering low-dose CT lung screenings for half price, $95.”

Sacred Heart launches low-dose CT screening for lung cancer
“Lung cancer is the leading cause of cancer death in the U.S. with about 175,000 new cases diagnosed each year and nearly 163,000 deaths annually. There are more options available for successful treatment when lung cancer is diagnosed in the early stages before the disease escapes the lung. Sacred Heart Hospital on the Emerald Coast now offers low-dose CT screenings for lung cancer for a flat rate of $199.”

Lima Memorial offers free lung cancer screenings
LIMA —“In observance of National Lung Cancer Awareness Month, Lima Memorial will offer a limited number of free low-dose lung screenings to those at high risk for the disease in November. The screening is for smokers and former smokers age 55-79 with a 30 pack-year history or age 50 with a 20 pack-year history and additional risk factors. The screenings will be funded by the Lima Memorial Hope Fund, developed to support Lima Memorial Health System patients with oncology related needs.”

October

Week Ending October 26, 2013

Early CT scans for smokers are discovering lung cancers
Brad Smallwood, a smoker for 40 years, prepares to enter the CT scanner, run by outpatient imaging technician Jen Lawhun.

4D scans aid cancer fight
A NEW weapon to fight one of the country's biggest-killing cancers promises more personalised and precise treatment. Results of a new trial show a world-first 4D imaging technique helps doctors better preserve lung cancer patients' breathing capacity while they blast their cancer cells with radiation.

UPDATED: Bristol-Myers adds promising survival update on breakthrough cancer drug
Bristol-Myers Squibb has added a few more brushstrokes to the very promising picture that's emerging from early-stage studies of nivolumab, a top PD-1 checkpoint receptor inhibitor billed as a major breakthrough in cancer drug research.

Researchers identify molecule that could aid lung cancer detection, treatment
Researchers at Boston University School of Medicine (BUSM) have discovered a molecule that could help lead to the non-invasive detection of lung cancer as well as its treatment.

Synta Announces Positive One-Year Follow-up Results for the GALAXY-1 Trial of Ganestespib in NSCLC at the World Conference on Lung Cancer
Synta Pharmaceuticals Corp. today announced presentation of results from the GALAXY-1 trial, a global, randomized, multi-center study designed to identify the patients with advanced non-small cell lung adenocarcinoma most likely to benefit from second-line treatment with the Company's lead drug candidate, the Hsp90 inhibitor ganetespib, in combination with docetaxel versus docetaxel alone.

Salem Health detects early lung cancer
Salem Health’s pilot lung cancer screening program has evaluated 240 current and former heavy smokers – and saved one life – since its inception in January, hospital officials said this week.

Fear of Lung Cancer Surgery
It’s important for physicians to be aware of cultural beliefs in different races. An interesting example of this comes from Philadelphia. Chest surgeons at the Veterans Affairs Medical Center in that city observed that patients undergoing evaluation for surgery for lung cancer had an unusual, but serious belief; they thought that lung cancer spreads if exposed to air (as during surgery). Obviously, patients holding this conviction would be far less willing to have surgery for their cancer.

New Research - Acupuncture Helps Lung Cancer Patients
A groundbreaking new study concludes that acupuncture treatments correlate to improvements in symptoms experienced by lung cancer patients. The study notes that lung cancer patients experience pain, depression, anxiety, nausea and a lack of well-being associated with either the disease or cancer treatments. The researchers discovered that a minimum of six acupuncture treatments was required to exert a 70% chance of a “clinically important improvement in well-being.”

Week Ending October 20, 2013

WHO agency: Air pollution causes cancer
LONDON — “What many commuters choking on smog have long suspected has finally been scientifically validated: air pollution causes lung cancer.”

Potential new drug for some patients with treatment-resistant lung cancer
BOSTON — “The investigational drug AZD9291, a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.”

Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
BOSTON — “PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.”

Two Peoria hospitals offer free lung cancer screenings in November
PEORIA – “When David Kimball learned UnityPoint Health-Methodist was having a sale on lung cancer screenings, he immediately said "I want a refund."”

Free lung cancer screens for former smokers
“Based on the success of Norwalk Hospital’s low-dose CT (computed tomography) lung cancer-screening program, the hospital is now offering free lung cancer screenings for people who are at risk.”

Research shows a simple blood test may determine if you have lung cancer
“Indi (Integrated Diagnostics) scientists have found that people with lung cancer have high levels of a certain proteins in their blood, that can distinguish between benign lung nodules and early-stage lung cancer.”

VATS lobectomy may be preferred in COPD with non-small-cell lung cancer
“Study Rundown: For patients with non-small-cell lung cancer (NSCLC), pulmonary lobectomy is often the recommended surgical intervention. In patients with comorbid COPD however, this surgery can result in serious post-operative pulmonary complications. The authors analyzed the post-operative outcomes in 283 COPD patients who underwent either VATS lobectomies or lobectomies by thoracotomy to remove NSCLC.”

Week Ending October 13, 2013

Giving a Voice to Lung Cancer
For the fifth year, Hildy Grossman will be singing for lung cancer research.
“Her organization, Upstage Lung Cancer, is a non-profit organization composed of lung cancer survivors, dedicated physicians, performing artists, friends, and family dedicated to fighting lung cancer. Upstage Lung Cancer is presenting a one-night-only benefit concert, I Could Have Danced All Night—Celebrating the Life and Lyrics of Alan Jay Lerner, on Tuesday, November 5, 2013, at 7:30 p.m. at The Lyric Stage in Boston. The evening also includes a silent auction and a wine & dessert reception. For more information or to purchase tickets, visit www.upstagelungcancer.org/events.php.”

Bay Area bride given $50,000 dream wedding dies from lung cancer
“Jen Bulik-Lang died Thursday from lung cancer, less than three months after she married husband Jeffrey Lang. Their dream wedding showcased the generosity of the community, and catapulted their heartbreaking story into the national spotlight.”

Lung cancer treatment helps patients with abnormal ALK gene
LOS ANGELES (KABC) --  “There are few treatment options when it comes to getting rid of lung cancer. The most common course is to operate, then follow up with radiation and chemotherapy. Now, a new drug is helping people with a certain type of lung cancer live longer without the harmful side effects of chemo.”

Cancer killer may be lurking right inside your home
THE ISSUE: Radon gas; OUR OPINION: More focus being placed on curbing No. 2 cause of lung cancer

“It’s such a constant message over time that the two have become synonymous: Smoking and lung cancer. Though the disease can be caused by multiple other factors than use of tobacco products, smoking remains the No. 1 cause of lung cancer. Not smoking is the prescribed preventive mechanism.”

Annual CT screening for lung cancer should continue at least five years
NEW YORK (Reuters Health) – “In smokers and former smokers, annual lung cancer screening with low-dose (LD) CT scans should not be discontinued after a negative result, according to an Italian study.”

Endocyte Announces DSMB Recommendation for Continuation of Vintafolide/Docetaxel Combination and Docetaxel Monotherapy Arms of the Phase 2b TARGET Trial in Non-Small Cell Lung Cancer
“Endocyte, Inc., a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced the outcomes of the planned independent Data Safety Monitoring Board (DSMB) review of the interim futility analysis for the Phase 2b TARGET trial with investigational candidate vintafolide (MK-8109/EC145).”

Immunotherapy induces ‘striking’ responses in non–small cell lung cancer
AMSTERDAM – “Almost a quarter of patients with advanced and heavily pretreated lung cancer responded to treatment with the novel immunotherapy MPDL3280A in an ongoing phase I study.”

Older Cancer Survivors in Rural Areas Get Less Care
“A new study looking at location and care for older cancer survivors didn't surprise me with the results. People over 65 with cancer, who live in rural regions, are 66% less likely to receive follow-up medical care after cancer.”

Nearly one quarter of lung cancer patients respond to Merck’s cancer drug
 (Reuters) – “Early data from a small trial of Merck & Co Inc's experimental immunotherapy cancer drug, known as MK-3475, showed that about a quarter of lung cancer patients responded to the treatment.”


September

Week Ending September 29, 2013

Roche immunotherapy drug may be "game changer" in lung cancer

  • Engineered antibody drug helps immune system fight cancer
  • Early trials promising for lung cancer in smokers
  • Lung tumours normally notoriously difficult to treat
“An experimental Roche drug that seems to work particularly well against lung cancer in smokers may be a "game changer" for these normally difficult-to-treat patients, researchers said on Sunday.”


Antidepressant kills lung cancer cells, research finds
“Stanford University researchers say a rarely used antidepressant can kill lung cancer cells.”

Redefining the criteria for ALK-positive lung cancer
“The current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. Findings from a new study suggest that doctors should look closer at borderline or atypical anaplastic lymphoma kinase (ALK)-negative cases, and it may widen the population of lung cancer patients who are offered treatment with crizotinib or other ALK-inhibitor drugs.”

Verastem begins Phase II study of lung cancer drug
“US-based biopharmaceutical company Verastem has started a Phase II clinical trial of defactinib (VS-6063), a potent inhibitor of focal adhesion kinase (FAK), in KRAS-mutated non-small cell lung cancer (NSCLC).”

Myriad Genetics' myPlan(TM) Lung Cancer Test Meets Primary Clinical Endpoint.
“Myriad Genetics, Inc. today announced new data published in Clinical Cancer Research that showed the myPlan Lung Cancer test is a significant predictor of lung cancer death in patients with early-stage, resectable lung adenocarcinoma and may be a valuable tool for selecting which early-stage patients should be considered for additional post-surgical chemotherapy.”

Merck KGaA lung cancer vaccine to re-enter Phase III
“When Merck KGaA's lung cancer vaccine Stimuvax flunked Phase III trials in December, many thought the project was dead. Merck continued to work on the compound though, and now, having probed the improvements seen in some patients in the last trial, is heading back to the clinic.”

GTx Announces Late Breaker Presentation on Results from the two Phase 3 POWER Trials of enobosarm, a selective androgen receptor modulator (SARM), for the prevention and treatment of muscle wasting in NSCLC patients during 2013 European Cancer Congress
“GTx, Inc. (Nasdaq: GTXI) announced today that top line results from the two Phase 3 trials (POWER1 and POWER2) on the effects of enobosarm for the prevention and treatment of muscle wasting in non-small cell lung cancer patients will be presented on September 28, 2013, at the European Cancer Congress 2013 (September 27-October 1, 2013) in Amsterdam.”

Patient-Reported Outcomes Provide Valuable Insight Regarding Quality of Life for Patients with Non-Small Cell Lung Cancer
Analysis of RTOG 0617 trial evaluates the impact of high-dose radiation therapy

“An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also suggests that lung cancer patients who received intensity modulated radiation therapy (IMRT) reported less decline in their QOL compared to those receiving three-dimensional conformal radiation therapy (3-D CRT).”

Week Ending September 22, 2013

Biomarker Can ID Smoking-related Lung Cancer
“Mayo Clinic researchers have shown that a specific protein pair may be a successful prognostic biomarker for identifying smoking-related lung cancers. The protein— ASCL1— is associated with increased expression of the RET oncogene, a particular cancer-causing gene called RET. The findings appear in the online issue of the journal Oncogene.”

Patients at highest risk for lung cancer benefitted most from low-dose CT screening
“Patients at the highest risk for lung cancer derived considerable benefit from low-dose CT screening, but the screening method prevented very few deaths among patients at lowest risk for the disease, according to study results.”

Leigh Barrett to Partner with Upstage Lung Cancer for Cabaret Benefit Concert, 11/5
“Reading's Leigh Barrett is joining forces with Upstage Lung Cancer (ULC), a non-profit organization comprised of lung cancer survivors; dedicated physicians, performing artists, friends and family dedicated to fighting lung cancer, to present a one-night-only benefit concert I Could Have Danced All Night - the Songs of Alan Jay Lerner on Tuesday, November 5, 7:30 pm at The Lyric Stage, 140 Clarendon Street, Boston. A wine and dessert reception and silent auction immediately follow the performance.”

Promising Marker for Response to EGFR Inhibitors
“The ratio of two protein levels may predict clinical benefit of oral epidermal growth factor receptor (EGFR) inhibitors. Low levels of a protein called Mig6 (mitogen-inducible gene 6) and high levels of EGFR corresponded to a higher clinical response rate and progression-free survival in a small prospective cohort of lung cancer patients treated with the EGFR-inhibitor gefitinib(Drug information on gefitinib).”

New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments
Kettering Medical Center is first in US to treat patient with Elekta's Versa HD radiation therapy system

“On September 4, Kettering Medical Center (Kettering, Ohio) became the first clinic in North America to use Elekta's Versa HD™ system to treat a patient, a 71-year-old woman with medically inoperable lung cancer.”

UT Southwestern Study Reveals Interference with Cellular Recycling Leads to Cancer Growth, Chemotherapy Resistance
“Overactivity of a protein that normally cues cells to divide sabotages the body's natural cellular recycling process, leading to heightened cancer growth and chemotherapy resistance, UT Southwestern Medical Center researchers have found.”

Lung Cancer Screenings Can Help Save Lives
“Franciscan Alliance has joined the war against lung cancer, the leading cause of cancer deaths in the U.S., through a potentially life-saving screening initiative that can uncover problems and lead to treatment.”

Monmouth Medical Center Lung Cancer Program Joins Int'l Organization
“Monmouth Medical Center, a Barnabas Health facility, recently announced it has joined the International Early Lung Cancer Action Program (I-ELCAP), an international, collaborative group consisting of experts on lung cancer and related issues from around the world.”

Week Ending September 15, 2013

Report finds crisis in cancer care from aging boomers, complexity of therapies, rising costs
WASHINGTON — “The U.S. is facing a crisis in how to deliver cancer care, as the baby boomers reach their tumor-prone years and doctors have a hard time keeping up with complex new treatments, government advisers reported Tuesday.”

LUNGevity Announces 2013 Lung Cancer Early Detection Research Awards
WASHINGTON, Sept. 12, 2013 /PRNewswire-FirstCall/ -- “LUNGevity Foundation, the largest lung-cancer focused funder of research in the U.S., announced that it has awarded $400,000 in new lung cancer research funds to two outstanding researchers through its Lung Cancer Early Detection Research program.”

Yorkers sought for national cancer study
“The American Cancer Society hopes to attract 150 people from York to participate in a national study that aims to link types of cancer with lifestyle factors.”

China Approves Ventana Assay to ID Patients for Xalkori
“Ventana Medical Systems Inc., a member of the Roche Group, announced the approval of the Ventana ALK immunohistochemistry (IHC) assay by the Chinese Food and Drug Administration (CFDA) as a companion diagnostic to aid in the identification of patients for Pfizer's CFDA-approved oncology product Xalkori (crizotinib). The Ventana ALK (D5F3) Rabbit Monoclonal Primary Antibody assay is designed to identify ALK-positive patients in non-small cell lung cancer (NSCLC) patients.”

North Texas cancer patient sees kindred spirit in 'Dancing' contestant Harper
DALLAS – “Nothing can stop Joellyn Eubank from taking a trip this weekend. Not even Stage 4 lung cancer that spread to her abdomen.”

New mutation identified, associated with better survival in lung cancer patients
“Japanese researchers have identified a mutation associated with a higher incidence of lung cancer in Japanese women who do not smoke, but better survival in lung cancer patients. In a study published today in the journal PLOS ONE, the team from the RIKEN Center for Life Science Technologies shows that a single nucleotide polymorphism (SNP) in a gene that protects cells from oxidative stress is found four times more frequently in women than in men.”

UC Davis Patient Embraces Personalized Approach to Lung Cancer DiagnosisPerspectives
Newswise — “As a woman in her mid-forties who didn’t smoke, Elizabeth Lacasia never expected to be diagnosed with lung cancer. But in 2006, after she developed a persistent and serious cough, a chest X-ray and CT scan revealed several tumors in her lower left lung.”

Week Ending September 8, 2013

Ontario researchers develop evidence-based recommendations for lung cancer screening
“Lung cancer is the most common cause of cancer death in Ontario. Screening for lung cancer using low-dose computed tomography (LDCT) has been the subject of many research studies since the 1990s. The National Lung Screening Trial compared LDCT with chest radiograph in high-risk populations and found a 20 percent reduction in lung cancer mortality at 6 years with LDCT after an initial scan and two annual rounds of screening.”

Lung diseases cause one in 10 deaths across Europe
Lung conditions are the cause of one in 10 of all deaths in Europe and smoking is a major factor, says a report from the European Respiratory Society.

“It says deaths from lung cancer and chronic obstructive pulmonary disease (COPD) will rise over the next 20 years because of past smoking rates.”

Survival Between Black and White Lung Cancer Patients is Similar
“A recent study looks at the racial difference between people of the same socioeconomic status regarding lung cancer patients, finding that there was relatively no difference among the participants involved.”

New CT scan program helps detect early lung cancer for current, former smokers
“A new screening program at Franciscan St. Elizabeth Health will help patients identify early stages of lung cancer.”

State Rep. Rose speaks out on lung cancer
CT – “State Rep. Kim Rose (D-Milford), a lung cancer survivor and strong advocate in raising awareness about the devastating and increasing lung cancer trend across the nation, recently lauded a proclamation issued by Gov. Dannel P. Malloy to mark Aug. 1 as Lung Cancer Day in Connecticut.”

Chronic Exposure to Air Pollution Linked with Heart Disease, Lung Cancer
Researchers have found that long-time exposure to ozone, a greenhouse gas prevalent in urban areas, can raise the risk of cardiovascular disease.

“The study was conducted by researchers at the University of California, Berkeley and colleagues who also found a strong association between nitrogen dioxide and an increased risk of death from lung cancer.”

Lung Docs to Focus on CT Screening Debate
BARCELONA – “The city known for Gaudí and Picasso will play host to controversy over early detection of lung cancer and new data on hot topics like e-cigarettes, hard-to-manage tuberculosis, and the electronic nose at the European Respiratory Society meeting.”

Non Smoker; You can still get Lung Cancer
“If you still stick to a hitherto belief that smoking is the only cause for lung cancer, then you may have to bring some change to the same.

According to some scientists from the Florida campus of The Scripps Research Institute (TSRI), a well-known cancer-causing gene is crucial in non-small cell lung cancer. This is the most common of different types of lung cancer.”

Smokers with clear lungs still have cancer signs
“Smokers whose lungs appear to be clear are in fact harboring airway cells that show early signs of impairment similar to that found in lung cancer, researchers have discovered. Physical examinations, lung function tests, and chest x-rays are not sensitive enough to pick up these very early changes, leading patients to mistakenly believe that they have incurred no smoking-related lung damage.”

App helps predict lung cancer from CT scans
TORONTO – “Canadian researchers have developed a software app that they hope will improve lung cancer screening around the world.”

Women Smokers Face Same Lung Cancer Risk As Men
“Women who smoke face the same or very similar risk of developing lung cancer as men who smoke, this according to the findings of a study.”

Week Ending September 1, 2013

MITA lauds AATS for endorsing lung cancer screening
“The Medical Imaging & Technology Alliance (MITA) today lauded the American Association for Thoracic Surgery (AATS) for endorsing the United States Preventive Services Task Force's (USPSTF) draft recommendation for annual CT scans for high-risk smokers.”

Vietnam veterans exposed to Agent Orange, increased cancer risk – study
“A new study appears to back concerns Vietnam War veterans have about Agent Orange.

The research by the University of Otago's Department of Preventive and Social Medicine shows Vietnam veterans who served from 1962-1971 have double the rate of chronic lymphatic lukemia compared to the general population.”

Preventive lung cancer screenings coming
“Local health systems are working to enhance their lung cancer screening programs driven by evidence that better, and earlier, detection can shrink death rates by 20 percent.”

Reducing death by lung cancer
High-risk patients being urged to get screenings

PORTSMOUTH — “A government agency is recommending annual lung cancer screenings for high-risk patients, saying studies indicate it may reduce by 20 percent the mortality rate for this too often deadly disease.”

Stage 4 cancer disappears; survivor credits faith, not medicine
“Hal Hart is a man of faith.

So much so he trusted God to wash away the Stage 4 bone cancer and metastatic lung cancer that consumed his torso, lodged a golfball-sized tumor in his neck, robbed his compact frame of 30 pounds, and wracked his body with pain so intense he couldn’t bend over.”

Taiwan researchers unlock reishi mushroom's cancer-fighting secret
Taipei, Aug. 30 (CNA) Scientists at Academia Sinica have cracked the mystery of how the polysaccharides in the reishi mushroom act to activate the human immune system and fight against cancer, and have shared their discovery with the world.

RMC performs new lung cancer treatment
“Intense, focused radiation bombarded Joyce Spencer's body several times in Anniston last week.”

Comprehensive Lung Cancer Screening at UC Davis
“UC Davis CLSP is a multidisciplinary program for comprehensive lung cancer screening. The innovative program provides low-dose chest computed tomography (LDCT) technology to detect lung cancer early in its most treatable form in those individuals at the highest risk for lung cancer.”

John Muir Health to Implement New, National Lung Cancer Screening Recommendation for High-Risk Patients
Key research by physicians and staff contributed to landmark decision

WALNUT CREEK, Calif. – “Since 2007, John Muir Health’s Clinical Research Center has been participating in a large-scale research project alongside dozens of other hospitals around the world as part of the International Early Lung Cancer Action Program (I-ELCAP) and has screened 250 patients to date. The study quantifies the benefits of low dose CT scans for early lung cancer detection in high-risk patients – current and former heavy smokers ages 55 to 80.”

Funds to support study of telephone-based treatment program for lung cancer patients
“An assistant professor of psychology in the School of Science at IUPUI will apply nearly $1 million in recently approved grants to study how a telephone-based treatment process can help ease stress and anxiety issues experienced by advanced-stage lung cancer patients and the family members who care for them.”

August

Week Ending August 27, 2013

LungCAN Celebrates Lung Cancer Screening Breakthrough
“The Lung Cancer Action Network (LungCAN), a collaborative group of 21 lung cancer advocacy organizations, today unanimously endorsed lung cancer screening recommendations recently released in draft form by the U.S. Preventive Services Task Force (Task Force).”

Acupuncture Reduces Pain in Lung Cancer Patients - New Findings
“New research finds acupuncture effective for the treatment of lung cancer symptoms. The focus of the study was the evaluation of acupuncture and its effect on lung cancer related symptoms such as nausea, anxiety, pain, depression and a sense of not feeling well. A total of 33 lung cancer patients received 45 minute acupuncture treatments at a rate of 1 - 2 times per week for at least 4 treatments.”

RWJ Hamilton offers low-cost lung cancer screenings
HAMILTON — “Robert Wood Johnson University Hospital has initiated a low cost lung cancer screening program for high-risk current and former smokers.”

Free CT Scan Recommendation for Lung Cancer Screening
MACON, Georgia (41NBC/WMGT) – “The United States Preventative Services Task Force recently recommended an early detection screening for lung cancer.”

Free screenings for lung cancer
Sharon, Pa. – “Sharon Regional Health System is offering free lung- cancer screenings as part of an ongoing community effort to aid in the early detection of lung cancer.”

Concerns over funding cuts for lung cancer nurses
UK – “Bolton North East MP David Crausby has met with lung cancer nurses to hear concerns over funding cuts.”

Boehringer to make lung cancer drug available in U.S.
“Boehringer Ingelheim Pharmaceuticals, with U.S. headquarters in Ridgefield, announced Thursday that Gilotrif oral tablets will become commercially available in the U.S. the week of Sept. 2.”

Talking about Smoking Cessation after a Diagnosis of Lung Cancer
“There are reasons that I seldom bring up smoking cessation when writing about lung cancer. One is strictly objective. The majority of people who are diagnosed with lung cancer today, in 2013, are non-smokers.”

Week Ending August 18, 2013

Lung cancer screening recommendation could affect DoD, VA care
An influential independent panel is recommending that heavy smokers over age 55 — a group that includes many military retirees and veterans — should be screened annually for lung cancer.

Breast cancer drugs 'could treat lung cancer'
Experimental drugs already used to treat breast cancer may also fight lung cancer, research reveals.

Non-small-cell lung cancer (NSCLC), the commonest type of lung cancer, is the leading cause of cancer deaths worldwide. Few drug treatments exist.

Mercer County area hospitals back low-radiation chest scans for early lung cancer detection
TRENTON -- Tens of thousands of people die each year from smoking-related causes, but somehow smokers don’t get the respect they deserve, says Dr. John Heim.

NICE denies Pfizer lung cancer drug in final guidance
In the past, the U.K.'s cost-effectiveness gatekeeper has shown that it will bend preliminary draft guidance decisions if the price is right. But for Pfizer ($PFE), which slashed costs on its targeted lung cancer drug Xalkori in hopes of gaining recommendation for its use in Britain's National Health Service (NHS), that price wasn't low enough.

Is phase III testing necessary for targeted cancer drugs with early and obvious benefit?
Generally, FDA-approved clinical trials progress through three phases: the first shows safety, the second determines efficacy and further evaluates safety, and the third seeks to prove a drug's superiority over existing treatments. But when a drug's benefit is obvious in the first or second phase, is the third, and costly, phase needed?

Eli Lilly lung cancer drug improves patient survival in trial
An experimental lung cancer drug from Eli Lilly & Co. increased survival among patients with advanced disease compared with those on chemotherapy alone, a study showed.

Italian Study Says Thyroid Drug May Increase the Risk for Lung Cancer...Does It?
Many people have been asking me about an Italian study that looked at levoxythine and lung cancer, learning about it via a GreenMedInfo article titled: "Study: Millions Treated for Hypothyroidism At Risk for Lung Cancer."

Fracking Can Lead to Lung Cancer, US Scientists Claim
Fracking poses a significant health risk to workers involved in the shale gas drilling process being pushed by Whitehall.

Week Ending August 11, 2013

Lung cancer support group first goal of Catholic Central administrator’s retirement
Man who helped right Catholic Central’s financial ship leaves job to concentrate on his health.

“Patrick Hearlihy’s composure has stepped away from him twice since his April 25 diagnosis with non small cell lung cancer, a virulent form of the disease.”

Moffitt Cancer Center Researchers Identify Gene Variations in Lung Cancer Patients That May Help Predict an Individual’s Treatment Response
TAMPA, Fla. – “Researchers at the Moffitt Cancer Center have identified four inherited genetic variants in non-small cell lung cancer patients that can help predict survival and treatment response. Their findings could help lead to more personalized treatment options and improved outcomes for patients.”

Lung cancer pill shows promise, CU patient is beating the odds
DENVER — “Last year, lung cancer killed more men and women in the United States than prostate, pancreatic, breast and colon cancer combined.”

Hospital Offering New Screening for Early-Stage Lung Cancer
“As the leading cause of cancer death in both men and women in the United States, lung cancer claims more than 160,000 lives annually.”

Discovery May Help Pinpoint Risk of Lung Cancer Returning After Surgery
(HealthDay News) – “Certain characteristics of tumors in lung cancer patients are associated with a strong risk of cancer recurrence after surgery, according to a new study.”

Delta Medix launches Lung Cancer Screening Program
“With Northeast Pennsylvania's incident rate for lung and bronchus cancer 14 percent higher than the national average, a local health care provider has announced plans for a screening program that could improve survival rates by 20 percent.”

Boehringer Ingelheim highlights positive new lung cancer trial data
“Boehringer Ingelheim has announced that data from a new clinical trial of its lung cancer therapy afatinib has been published in the Journal of Clinical Oncology.”

Week Ending August 4, 2013

Older smokers should get CT scans for lung cancer, panel recommends
“Many older smokers and former smokers should undergo annual CT scans for lung cancer, an influential health panel recommended for the first time Monday, suggesting that early detection of the leading cause of cancer deaths could save more than 20,000 lives every year.”

Lung Cancer Patient Becomes Zookeeper for a Day
“Michalene Sullivan got to cross something off her bucket list on Friday. The Lake Superior Zoo helped her to become a zookeeper for a day.”

At the Top of My Lungs: Newlyweds Living with Lung Cancer
“At the top of my lungs. This phrase has a whole new meaning for me now.”

R.J. Reynolds Tobacco Company Loses $37.5 Million Battle Over Lung Cancer Victim
“A South Florida jury this week found the R.J. Reynolds Tobacco Company partially responsible for the death of smoker Laura Grossman, who in 1995 died of lung cancer at the age of 38. The jury awarded $37.5 million to Grossman's family, which included $22.5 million in punitive damages against the tobacco company to deter R.J. Reynolds from trying to lure teenagers in the future, according to Marketwired.”

Obesity increases death risk for patients with non-small cell lung cancer
“When the impact of obesity on outcomes was studied among patients with advanced non–small cell lung cancer (NSCLC), obese patients had superior outcomes early on but had increased hazards later.

From 1993 to 2004, the Eastern Cooperative Oncology Group enrolled 2,684 patients in three phase III trials of first-line systemic chemotherapy for advanced NSCLC. The body mass index (BMI) of 2,585 eligible patients was calculated. The median follow-up was 64.9 months. As with the general population, 4.6% of the patients were underweight, 44.1% were normal weight, 34.3% were overweight, and 16.9% were obese.”

Fear of Lung Cancer Surgery
“It’s important for physicians to be aware of cultural beliefs in different races. An interesting example of this comes from Philadelphia. Chest surgeons at the Veterans Affairs Medical Center in that city observed that patients undergoing evaluation for surgery for lung cancer had an unusual, but serious belief; they thought that lung cancer spreads if exposed to air (as during surgery). Obviously, patients holding this conviction would be far less willing to have surgery for their cancer.”

Personalizing lung cancer care through biomarker testing
“The concept of personalized medicine – matching a patient’s unique genetic profile with an appropriate and more individualized treatment plan – is transforming the care of patients with cancer.

Over the last decade, the scientific community has gained a greater understanding of genetic mutations, or abnormalities, associated with the development and progression of cancer; these mutations are also known as biomarkers. The presence or absence of a biomarker can help physicians determine the most appropriate treatment approach for each individual patient based on their specific type of cancer.”

July

Week Ending July 28, 2013

Lung Cancer in Women
“Lung cancer has traditionally been viewed as male disease; but, lung cancer does not discriminate. According to the American Cancer Society, lung cancer is the leading cause of cancer deaths among American women, killing more women each year than breast cancer, uterine cancer and ovarian cancer combined.”

The Role of Acupuncture for Lung Cancer Symptoms
“More and more cancer centers are offering integrative treatments for cancer. That is, they are offering alternative therapies such as acupuncture and massage to help control the symptoms of cancer, while at the same time recommending traditional treatments such as surgery, chemotherapy and radiation therapy.”

Screenings, radiation help those with lung cancer
“In 2013, an estimated 159,480 people will die from lung cancer in the United States, approximately three times as many as from colon cancer, the second deadliest U.S. cancer, according to projections by the American Cancer Society.”

Researchers explore impact of obesity on outcomes of patients with advanced non-small cell lung cancer
“Obesity increases health risks for many things. Researchers wanted to know the impact of obesity on outcomes of patients with advanced non-small cell lung cancer. In the September issue of the International Association for the Study of Lung Cancer's journal, the Journal of Thoracic Oncology (JTO), researchers conclude that obese patients had superior outcomes early on in the study, but then experienced increased hazards.”

Gene Expression Test Shows Promise for Lung Cancer Diagnosis
“An assay system for gene expression analysis of paraffin (Drug information on paraffin)-embedded patient samples is predictive of lung cancer histologic type, according to results published in the Journal of Molecular Diagnostics.”

Crizotinib Ups PFS in ALK-Positive NSCLC
“The anaplastic lymphoma kinase (ALK)-inhibitor crizotinib leads to longer progression-free survival than chemotherapy in patients with advanced ALK-positive non–small-cell lung cancer (NSCLC), according to results of a phase III clinical trial published in the New England Journal of Medicine.”

Need for national Canadian strategy for EGFR testing
“Significant advances have taken place in the management of patients with advanced and metastatic non–small-cell lung cancer (NSCLC) over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar manner. More recently, the importance of pathologic subtype has been recognized. Data from several randomized trials demonstrate that epidermal growth factor (EGFR) mutation status is predictive of improved survival and quality of life with selected systemic therapies.”

Lung cancer warning for Redbridge residents after disease claims nearly 100 lives in a year
“The Redbridge Clinical Commmissioning Group (CCG) is urging people to go to see their GP if they have had a cough for three weeks or more.”

MRH using SBRT for non-surgical treatment of stage 1 lung cancer
“For almost a year now, a piece of equipment with the intimidating name of the Trilogy Stereotactic Linear Accelerator has provided a previously unavailable treatment option for patients with brain tumors at FirstHealth Moore Regional Hospital, Pinehurst.”

Karmanos Cancer Center launches Lung Cancer Screening Program to help detect lung cancer
“The Barbara Ann Karmanos Cancer Center is launching a Lung Cancer Screening Program for adults with a history of smoking – both current and former smokers. The goal of the program is to help detect lung cancer early with the help of low-dose CT (computed tomography) scans. Karmanos is able to offer the lung cancer screening for the reduced cost of $100, thanks to the generous support of the Gianni Ferrarotti Lung Cancer Foundation which is partially underwriting the expense.”

Week Ending July 21, 2013

USFDA approves Gilotrif (afatinib)
Boehringer Ingelheim announced that the US Food and Drug Administration has approved afatinib tablets under the US brand name GILOTRIFTM for oral use.

“Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved afatinib tablets under the US brand name GILOTRIFTM for oral use, as a new first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.2.”

Roche Launches ProGRP Test to Aid Differential Diagnosis of SCLC and NSCLC
“Roche announced the global (ex-US) launch of its Elecsys ProGRP (progastrin-releasing peptide) test for distinguishing between small cell (SCLC) and non-small cell (NSCLC) lung cancer. The assay is designed for use on Roche’s cobas modular analysers. Correct differential diagnosis of lung cancer type is important because SCLC and NSCLC need to be treated differently. Early-stage NSCLC can be cured by surgery, while SCLC is treated with chemo- and radiotherapy. Elecsys ProGRP has been developed to aid in this early differential diagnosis and treatment decision making.”

Lung cancer signs even in "healthy" smokers
“Smokers who have been given a clean bill of health from their doctors after normal examination results may still have early signs of lung cancer, according to a study published in the journal Stem Cells.”

RNA diagnostic test from paraffin improves lung cancer diagnosis over routine microscopic evaluation alone
CHAPEL HILL – “Knowing what type of lung cancer a patient has is critical to determine which drug will work best and which therapies are safest in the era of personalized medicine. Key to making that judgment is an adequate tumor specimen for the pathologist to determine the tumor’s histology, a molecular description of a tumor based on the appearance of cells under a microscope. But not all specimens are perfect, and are sometimes so complex that a definitive diagnosis presents a challenge.”

Week Ending July 14, 2013

FDA approves new treatment for a type of late-stage lung cancer
“Today’s approvals further illustrate how a greater understanding of the underlying molecular pathways of a disease can lead to the development of targeted treatments,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. “Gilotrif is the second drug approved this year for patients with untreated metastatic NSCLC whose tumors have the EGFR exon 19 deletions or exon 21 L858R substitution mutations.”

Europe-wide study finds long-term exposure to even low levels of air pollution increases risk of lung cancer
"At this stage, we might have to add air pollution, even at current concentrations, to the list of causes of lung cancer and recognise that air pollution has large effects on public health", warns Takashi Yorifuji from Okayama University Graduate School of Environmental and Life Science and Saori Kashima from Hiroshima University in Japan in a linked Comment.

Genetic screen finds new treatment targets for lung cancer
Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research published in PNAS, today (Monday).

Potential Biomarker To Identify Disrupted Micronuclei In Solid Tumors
In a new study, published in Cell, a team of scientists at the Salk Institute for Biological Studies finds that disrupted micronuclei, which can trigger massive DNA damage on chromosomes, might play an even more active role in carcinogenesis than previously thought. They also found that disrupted micronuclei can be an objective biomarker for the genetic instability common to many solid tumors, including non-small cell lung cancer (NSCLC).

Week Ending July 7, 2013

Researchers Develop MRI Scan To Detect Cancer Using Sugar
Dr. Simon Walker-Samuel from the UCL Centre for Advanced Biomedical Imaging says: "We have developed a new state-of-the-art imaging technique to visualize and map the location of tumors that will hopefully enable us to assess the efficacy of novel cancer therapies."

Pepsi promises to stop using alleged carcinogen following pressure from health advocates
“Pepsi announced this week that it plans to remove a controversial chemical from soda sold in the US, more than a year after the state of California labeled it a carcinogen. The move was spurred by a report from the Oakland-based Center for Environmental Health (CEH), which found that PepsiCo's sodas still contain the chemical methylimidazole, or 4-MEI — a compound found in caramel coloring agents used in sodas, soy sauce, beer, and bread.”

Norwalk Hospital Earns Gold Award For Lung Cancer Care
“Norwalk Hospital has been recognized for taking the lead in the fight against lung cancer and has become the first hospital in New England to earn The Joint Commission’s Gold Seal of Approval for meeting its national standards for health care quality and safety in lung cancer care.”

Cancer Spread Aided By Blood Platelets That "Open Doors"
“Scientists in Germany believe they have found the mechanism that cancer cells use to coax blood platelets to "open doors" in blood vessel walls so they can pass through and get into new organs.”

New marker substance for cancer cells
“Scientists from ETH Zurich have developed a new substance that enables certain tumour types to be rendered visible in high resolution using positron emission tomography. The so-called tracer has successfully been tested in mice. Now the researchers are planning clinical trials in humans.”

June

Week Ending June 30, 2013

Lung cancer differs between women smokers and non-smokers
“Lung cancer between women smokers and non-smokers differs genetically, researchers in France say.”

Study shows autophagy blockers play a role in treatment of non-small-cell lung cancer
“New research from Rutgers Cancer Institute of New Jersey, Princeton University and other collaborators suggests that inactivation of an essential gene responsible for the cell survival process known as autophagy can suppress the growth of non-small-cell lung cancer tumors and render them more benign. The findings suggest a possible role for autophagy blockers in the treatment of this type of lung cancer, which has a five-year survival rate of only 30 to 50 percent for early-stage disease.”

WVU carries out clinical trial for new cancer drug
MORGANTOWN — “For people with stage four lung cancer, all they want is more time. A new clinical trial with the Mary Babb Randolph Cancer Center at West Virginia University hopes to prolong the survival rates of lung cancer victims.”

Cancer-free Palo Altans sought for study
Long-term project to track 300,000, seeking genetic, lifestyle links to cancer

“The American Cancer Society is seeking Palo Alto residents and others from San Mateo and Santa Clara counties for a nationwide study on environmental, genetic and lifestyle links to cancer.”

Trinity offering low-cost lung scans
“The UnityPoint Health-Trinity Lung CancerAware program is offering $175 lung scan tests to patients at high risk for the disease.”

NCH offers early lung cancer screening program
ARLINGTON HEIGHTS, Ill. (June 27, 2013) – “For smokers and former smokers, the risk of getting lung cancer is much higher than for non-smokers. But high-risk smokers can breathe a sigh of relief with a program at Northwest Community Healthcare (NCH) that diagnoses lung problems at the earliest possible stage.”

Week Ending June 23, 2013

Lung cancer surgery does not deter smokers
Half of patients having lung cancer surgery go back to smoking, according to study.

“The link between smoking and lung cancer is well known. You might think that having surgery for lung cancer would put people off smoking. This is not the case, according to researchers at Washington University School of Medicine. They studied 154 patients being treated for early stage lung cancer and found that nearly half of them started smoking again within a year of surgery.”

What do Patients Expect from Radiation Therapy for Lung Cancer?
“If you (or a loved one) are living with lung cancer, you've probably heard of radiation therapy as an option. If so, you wouldn't be alone. Roughly 50% of people with lung cancer receive radiation therapy at some time during their journey. But what are your expectations from this treatment, and what has your doctor shared with you about its effectiveness?”

New UT Dallas Research Studies Heme, Suggests New Approach to Fighting Lung Cancer
“The differences in the metabolism of malignant cells and normal cells can help in designing special anti-cancer therapies to combat lung cancer, as suggested by researchers at The University of Texas at Dallas. The results of the research published online in the scientific journal PLOS ONE compared the metabolic differences of normal lung cells and “non-small-cell” lung cancer cells taken from the same patient.”

Are We Winning The War On Cancer?
“Cancer affects the lives of millions of Americans each day, so it’s no wonder medical professionals consider the fight against it a war. Fortunately, cancer treatments are continuously improving, which makes dealing with this life-altering disease just a little easier.”

Lung Cancer Molecular Testing - Who Should Be Tested For Epidermal Growth Factor Receptor Mutations?
“One of the greatest advances in lung cancer treatment in recent years has been the use of medications that target epidermal growth factor mutations (EGFR mutations.) For people who test positive for this mutation, medications such as Tarceva (erlotinib) can extend survival and improve quality of life - all without the degree of side effects seen with other forms of chemotherapy.”

Novartis First-Generation Lung Cancer Drug Tweaked To Reduce Potential Side Effects
“Certain lung cancer tumors express an enzyme called anaplastic lymphoma kinase (ALK), which is critical to the cancer’s survival and spread. As a result, ALK is a popular drug target. Now researchers describe how they redesigned an ALK inhibitor to avoid toxicity issues and produce a promising drug (J. Med. Chem. 2013, DOI: 10.1021/jm400402q). The new inhibitor, currently in clinical trials to treat non-small-cell lung cancer, is on fast-track review with the Food and Drug Administration.”

Crizotinib Improves Progression-Free Survival in Some Patients with Advanced Lung Cancer
“Results from an international phase III trial show that crizotinib (Xalkori®) may benefit previously treated patients with advanced lung cancer whose tumors have a specific genetic mutation. The targeted therapy substantially extended the amount of time trial participants lived without their disease getting worse.”

Memorial Sloan-Kettering Offers New Type of Lung Cancer Screening for Smokers
“Some people at high risk for lung cancer due to smoking now have the option of being screened with a powerful method that has been proven to save lives. Memorial Sloan-Kettering’s new Lung Cancer Screening Program offers low-dose CT screening to current and former smokers who fit specific criteria in order to detect the disease at its earliest stage.”

Lung cancer remains a major killer
“The No. 1 killing cancer is not the one many people think of first. It's not the one with the pink ribbon, or the one whose controversial screenings are grabbing headlines. It's lung cancer. And even though it's the third-most commonly diagnosed type, behind prostate and breast cancers, it claims more than twice as many lives annually than both of those - combined.”

Week Ending June 16, 2013

New Research - Acupuncture Helps Lung Cancer Patients
“A groundbreaking new study concludes that acupuncture treatments correlate to improvements in symptoms experienced by lung cancer patients. The study notes that lung cancer patients experience pain, depression, anxiety, nausea and a lack of well-being associated with either the disease or cancer treatments. The researchers discovered that a minimum of six acupuncture treatments was required to exert a 70% chance of a “clinically important improvement in well- being.”

Advances in lung cancer screening aid early detection
“Lung cancer is the second most common type of cancer in the United States aside from breast cancer in women and prostate cancer in men. Yet in terms of cancer related mortality it causes more deaths than the combined deaths from breast, prostate and colon cancers.”

Project calls out lung cancer bias
“For many conditions, bias exists as a prominent symptom, whether it comes from within and/or all around. With lung cancer patients in particular, the effect and affect of biases seem especially strong, an assertion given even more bulk by the latest findings from The Lung Cancer Project.”

New lung cancer oncogene and target in NTRK1
“A subset of lung cancers are caused by mutations in the gene NTRK1, according to research presented at the annual meeting of the American Society of Clinical Oncology in early June in Chicago, Illinois.”

St. Louis CyberKnife Promotes SSM Cancer Care at St. Clare Lung Cancer Early Detection Initiative, Offers Treatment
“St. Louis CyberKnife joins efforts to raise awareness for its partner, SSM Cancer Care at St. Clare Health Center, newly launched preventive lung cancer screenings as part of the International Early Lung Cancer Action Program (I-ELCAP).”

Study Suggests Role for Targeting HER2 in Non-Small Cell Lung Cancer –
“Mutations of the human epidermal growth factor receptor 2 (HER2) gene in patients with non-small cell lung cancer (NSCLC), though rare, potentially could be treated with HER2-targeted drugs, according to a retrospective study in the Journal of Clinical Oncology.”

Twice as many lung cancers detected by CT as by X-ray at initial screening
“Centers in the United States can achieve a 20% reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening that was previously reported by the National Lung Screening Trial (NLST). This reduction is achievable at experienced screening centers in the US.”

Lung Cancer Alliance Announces $10.5 Million In Additional Federal Funding For Lung Cancer Research Has Cleared An Important Legislative Hurdle
Approved in FY2014 Department of Defense Lung Cancer Research Program For 6th Consecutive Year

“Today, Lung Cancer Alliance proudly announced that an additional $10.5 million for lung cancer research has been included in the House Appropriations FY2014 Department of Defense (DOD) funding bill.”

Week Ending June 9, 2013

Immunotherapy is not just for melanoma anymore
(Reuters) – “Diagnosed with advanced lung cancer over a year ago, Gabe Tartaglia was loath to undergo the kind of harsh chemotherapy that had devastated his sister before her death three years earlier from pancreatic cancer.”

Fear of Lung Cancer Surgery
“It’s important for physicians to be aware of cultural beliefs in different races. An interesting example of this comes from Philadelphia. Chest surgeons at the Veterans Affairs Medical Center in that city observed that patients undergoing evaluation for surgery for lung cancer had an unusual, but serious belief; they thought that lung cancer spreads if exposed to air (as during surgery). Obviously, patients holding this conviction would be far less willing to have surgery for their cancer.”

Inhalation Therapy for Lung Cancer Shows Promise in Rutgers Study
Animal studies indicate that delivering chemotherapy through inhalation significantly improves the rate of successfully treating lung tumors.

“Lung cancer kills about 1.5 million men and women around the world – more than the number of people who die from breast, colon, pancreatic and prostate cancers combined.”

Survival inferior with higher-dose radiotherapy for patients with stage III lung cancer
“The overall survival of patients with stage III non-small cell lung cancer (NSCLC) was not improved by high-dose radiotherapy, which was compared with standard-dose radiotherapy. Both treatment arms had concurrent chemotherapy. The trial was presented June 4 at the 2013 annual conference of the American Society of Clinical Oncology in Chicago, Illinois.”

Louisville CyberKnife Reports on Lung Cancer Prevalence in Kentucky, Provides Noninvasive Treatment Option
“Lung cancer incidence and mortality rates in Kentucky rank highest in the nation, the American Cancer Society reports. Men make up the majority of these cases as the disease kills more men in Kentucky than prostate cancer, colon cancer and pancreatic cancer combined.”

Guidelines recommend low-dose CT scans for those at high risk for lung cancer
“In the third edition of its lung cancer guidelines, the American College of Chest Physicians recommended low-dose CT scanning as a screening procedure for those at high risk for lung cancer.”

ASCO: Heat Shock Protein 90 Inhibitor Shows Promise in NSCLC
“Results from the GALAXY-1 trial showed that the novel second-generation heat shock protein 90 (HSP90) inhibitor ganetespib could potentially improve survival in patients with advanced-stage non–small-cell lung cancer (NSCLC).”

ASCO: Pemetrexed Plus Carboplatin No Better Than Bevacizumab-Containing Regimen in NSCLC
CHICAGO—“A phase III study comparing pemetrexed(Drug information on pemetrexed) and carboplatin(Drug information on carboplatin) with paclitaxel, carboplatin, and bevacizumab(Drug information on bevacizumab) failed to find a difference in a composite endpoint of progression-free survival and severe drug-related toxicities in patients with nonsquamous non–small-cell lung cancer (NSCLC), according to results presented at the annual meeting of the American Society of Clinical Oncology (ASCO).”

ASCO: TKI Offers Hope in Small Cell Lung Cancer
CHICAGO – “Maintenance therapy with the oral tyrosine kinase inhibitor sunitinib (Sutent) delayed relapse after chemotherapy in patients with extensive small cell lung cancer, a researcher said here.”

Targeting lung cancer genes improves outcome: study
“Lung cancer patients who received a drug designed to target a genetic dysfunction lived longer with fewer side effects than those who received traditional chemotherapy, a study showed.”

Race. Wealth. Gender. Cancer?
Conscious and subconscious perceptions influence the way we view race, wealth and gender. But what about cancer? Do we have a subconscious perception of – or even a bias against –

May 31st, 2013 – “The subconscious mind drives 80 to 90 percent of human behavior, so the answer in short is yes. After seeing a study at last year’s ASCO showing that many people with advanced lung cancer never receive cancer care, I began to wonder if specific subconscious perceptions such as stigma, shame and hopelessness had an impact on lung cancer treatment rates.”

Week Ending June 2, 2013

Biodesix Announces Results in Phase III Lung Cancer Diagnostic Study; First Prospective Biomarker-Stratified Validation Study in Oncology
“The findings from PROSE show that the VeriStrat test provides physicians with clinically useful information helping to guide therapy for lung cancer patients in the second-line setting,” said Dr. Gregorc. “For lung cancer patients, this test offers meaningful insight into which therapy, either EGFR-TKIs or chemotherapy, is likely to lead to the best survival outcome.”

Primary Progression-Free Survival Endpoint Met in Phase III Study of Nintedanib Plus Docetaxel in Second-Line Advanced NSCLC
“We are pleased to present the progression-free survival and overall survival data observed with the nintedanib/docetaxel combination in the LUME-Lung 1 clinical trial, in patients with advanced non-small cell lung cancer in the second-line treatment setting,” said Berthold Greifenberg, MD, vice president, Clinical Development and Medical Affairs, Oncology, Boehringer Ingelheim Pharmaceuticals, Inc. “These results were selected by ASCO for presentation at a late-breaking oral session at this year’s annual meeting.”

New drug 'extends advanced lung cancer survival'
"This is the first randomized study to demonstrate therapeutic benefit with a heat shock protein inhibitor in patients with cancer," said lead study author Suresh Ramalingam, a professor of medical oncology at Emory University in Atlanta, Georgia. "We hope that the ongoing Phase III study will confirm our findings, as patients with this common form and stage of lung cancer urgently need more effective treatments."

ASCO: Targeted Drug Tops Chemo for Lung Cancer
“Patients treated with crizotinib (Xalkori) had a median progression-free survival of 7.7 months, more than twice as long as patients treated with either of two chemotherapy regimens. Symptoms also improved significantly more with crizotinib than with chemotherapy, according to Alice T. Shaw, MD, PhD, of Massachusetts General Hospital.”

Iowa offers free help to quit smoking
During the entire month of June, The Iowa Department of Public Health (IDPH) is offering four weeks of free nicotine replacement therapy (NRT) in the form of patches and gum to Iowa smokers who choose to make a quit attempt using Quitline Iowa.

Best of ASCO coming soon!

May

Week Ending May 26, 2013

Lung cancer region's top cancer killer
“Lung cancer claims an inordinately high number of this region's residents each year and smoking is much to blame.

Lung cancer claims about 4,200 Tennesseeans annually, or one of every three people who succumb to some form of cancer. That total far exceeds the number of deaths due to colorectal, breast cancer, pancreatic androstate cancers combined, according to the Tennessee Department of Health.”

Lung cancer mystery
ATLANTA, Georgia (WXIA) – “Samantha Mixon looks and feels great, but she is fighting stage four lung cancer and all the assumptions that people make about her disease.”

Villalba turns sister’s lung cancer death into a cause
“Rep. Jason Villalba, R-Dallas, has sought to channel grief over his older sister’s death from lung cancer into greater public awareness of the killing disease.”

Lung Cancer Alliance Wins Big During Awards Week
“Lung Cancer Alliance announced today that it was awarded a Bronze Effie Award in the Disease Awareness and Education category, and a Silver OBIE Award for their "No One Deserves to Die" campaign. This first of its kind stigma busting campaign was designed to start a national conversation around ending the bias associated with lung cancer.”

New drug delivery system can help treat lung cancer
“Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs while significantly improving the treatment of lung tumors.”

Prophylactic Bilateral Lung Removal for Lung Cancer Prevention?
“Each time I hear a discussion about Angelina Jolie's choice to undergo a preventative mastectomy to lower her breast cancer risk - and that has been often these past few days - my heart turns to those I care about with lung cancer.”

Major Lung Cancer Advancement At Boca Regional
BOCA RATON, FL (BocaNewsNow.com) — “Boca Region Hospital continues to make news for its staff, facilities and equipment. The hospital today announced a major addition to its cancer treatment arsenal.”

Week Ending May 19, 2013

Lung Cancer, Not One Disease: Diverse Patients Need Personalized Treatments, Two New Studies Show
BURLINGTON, ON – “New research taking place right here on Canadian soil is shedding light on the nation's number one cancer killer,i lung cancer. Boehringer Ingelheim (Canada) Ltd. today announced data from Phase III clinical trials involving two different investigational oncology treatments - afatinib* and nintedanib* - in two distinct groups of patients with advanced non-small cell lung cancer (NSCLC). The research is further proof that lung cancer is not just one disease - it can affect anyone, not just smokers.”

FDA approves Roche diagnostic for gene mutation in lung cancer
(Reuters) – “U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in patients with the mutation whose cancer has spread beyond the lungs.”

Cancer survivor exudes calm in Legislature’s budget battles
Redmond Republican Andy Hill, the state Senate’s chief budget writer, learned a hard-won lesson when advanced lung cancer threatened his life four years ago. “The illness taught me not to sweat the small stuff,” he said.

OLYMPIA — “Republican state Sen. Andy Hill has a regular reminder of the advanced lung cancer that threatened his life four years ago — a dark orange capsule he takes twice a day.”

16-year-old finds a new way to detect cancer
(CBS News) “In our "Young Innovators" series, we've been featuring young people trying to change the world. This time, we spotlight Jack Andraka, who started googling ways to prevent cancer after losing a friend to the disease. And look where it took him.”

Lung biomarker testing hindered by insufficient tissue samples
“The biggest challenges faced in incorporating biomarker testing into the care of persons with lung cancer involve the ability to obtain tissue samples of sufficient size and quality, according to newly released survey findings. Biomarker testing, in which tissue is tested for a given genetic mutation or translocation, can be used to tailor treatment to a person's specific type of cancer.”

Study in hope
Research will look at best treatment options for advanced lung cancer

“The Callahan Cancer Center is one of four facilities participating in a new clinical research study aimed at Stage IV lung cancer patients. Enrollment will begin on July 1.”

Drugs Targeting Leukemia, Ovarian Cancer, And Lung Cancer To Begin Phase III, AstraZeneca Reports
The biopharmaceutical company, which operates in over 100 countries, has issued an update on its oncology pipeline for 2013.

“In 2013, AstraZeneca will be advancing three of its cancer drugs to Phase 3 clinical development, the global biopharmaceutical company reports. Leukemia, ovarian cancer, and lung cancer are the targets of the three compounds currently in development.”

Ultralow-dose CT bests X-Ray for lung cancer follow-up, but is it enough?
MINNEAPOLIS – “Minimal-dose computed tomography was superior to chest radiographs for surveillance after curative lung cancer resection in a randomized controlled trial involving over 300 patients.”

Stage 3A Lung Cancer Survival Better When Surgery Follows Chemo and Radiation
“There are several options for treatment with stage 3A lung cancer, but with options come choices. And sometimes there's no clear cut direction as to which choice is best. For example, stage 3A non-small cell lung cancer is often treated with a combination of surgery, chemotherapy, and radiation therapy, but the proper order of these treatments has been debated.”

Week Ending May 12, 2013

Human Immune-Boosting Cancer Drugs Seen Extending Lives: Health
“Merck & Co., Bristol-Myers Squibb Co. and Roche Holding AG (ROG) have opened a new front against cancer with the next generation of experimental drugs that use the human immune system to seek and destroy tumor cells.”

Cheryl G. Healton Recognized for Public Health Leadership at Prevent Cancer Foundation’s Lung Cancer Workshop X
“The Prevent Cancer Foundation is proud to announce Cheryl G. Healton, DrPH, as the first recipient of the James L. Mulshine, M.D., Leadership Award at the 2013 Lung Cancer Workshop X, held in Bethesda, Md. on May 2. The award recognizes Healton’s over 25 years of tireless work in public health, specifically on tobacco control. A former smoker herself, Dr. Healton’s first-hand understanding of addiction has driven her passion to find real-world solutions to smoking cessation.”

Study: No Association Between Cannabis Smoke and Risk of Lung Cancer
LOS ANGELES, CA — “In a recent presentation given at the annual meeting of the American Association of Cancer Research, investigators from the University of California, Los Angeles provided the latest data reaffirming that cannabis consumption is not associated with an elevated risk of lung cancer.”

Alan Ashworth: Enough of the back slapping, let's find a cure for cancer
The molecular biologist has revolutionised treatment of breast cancer. His next challenge? The lungs.

“Professor Alan Ashworth is on a mission. He made his name by helping to discover one of the key breast cancer genes and now he wants to destigmatise lung cancer, a disease tainted by its association with smoking and an unhealthy lifestyle.”

New Lung Cancer Guidelines Recommends Offering Screening To High-Risk Individuals
Advances in Treatment Have Major Impact on Short- and Long-term Outcomes NORTHBROOK, Ill., -- “The American College of Chest Physicians (ACCP) third edition of evidence-based lung cancer guidelines, Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, recommends offering low-dose computed tomography (LDCT) scanning for lung cancer screening to people with a significant risk of lung cancer due to age and smoking history.”

AATS: MnDCT Beats Chest X-Ray for Detecting Lung Cancer
“Minimal Dose Computed Tomography Scan of the Chest delivers a radiation dose comparable to that of chest X-ray, with greater sensitivity for detecting new or recurrent lung cancer, according to a study presented at the annual meeting of the American Association for Thoracic Surgery, held from May 4 to 8 in Minneapolis.”

Brain chemotherapy improves survival after lung metastasis
“Intraventricular chemotherapy, in which the drugs are injected directly into the ventricles of the brain, improved symptom response rate and overall survival among persons with leptomeningeal carcinomatosis (LMC) that developed from non-small cell lung cancer (NSCLC).”

Space Coast Cancer Center Adds Lung Cancer Services
BREVARD COUNTY, FLORIDA – “Space Coast Cancer Center is adding three new programs to their support and service offerings to cancer patients and the community at large.”

Targeted therapy helps lung cancer patients
“It's a sad fact that Kentucky not only leads the way in the number of people getting diagnosed with lung cancer, but also leads in lung cancer deaths as well. But new technology at the James Graham Brown Cancer Center in Louisville is putting a target on that statistic.”

UH offers $99 lung cancer screenings at 11 Northeast Ohio locations: The Frugal Patient
CLEVELAND, Ohio – “University Hospitals Case Medical Center continues to offer $99 lung cancer screenings for people who've smoked for years and are more likely to develop cancer.”

Why Aren’t More Lung Cancer Patients In Clinical Trials?
“Clinical trials can make a difference for some people living with lung cancer. I know. I have a friend who has bypassed her predicted survival by years via a medication obtained only through clinical trials. In addition, my brother's family has a grandparent that lived well beyond what doctors would predict - after the same drug became available to the general public (which was only possible through the participation of others in clinical trials.)”

April

Week Ending April 28, 2013

New cancer weapons: Blount Memorial breaking ground in lung cancer treatment, screening
“While lung cancer continues to be the No. 1 killer in the country among the four most commonly diagnosed cancers, the Blount Memorial Cancer Center is breaking new ground in lung cancer services and screening techniques.”

Frightening diagnosis also brought a new start
Joe Diana, a lung cancer survivor, is ready for the Broad Street Run five years after his surgery.

“In the summer of 2008, Joe Diana was 41, a smoker, overweight, and out of shape.

He was playing volleyball at a pool party. He was diving for a shot, hit the poolside, and thought he broke a rib. He went to the emergency room.”

Radon threat grabs attention of lawmakers
GOLDEN VALLEY, Minn. – “You can't see it. You can't smell it. But health officials believe radon gas causes tens of thousands of lung cancer deaths every year.”

Testing Lung Cancer Patients for Gene May Aid Treatment, Study Finds
For those with the gene, drugs appeared to extend survival without spread of disease by several months

“Lung cancer patients carrying a rare gene mutation may experience delayed disease progression with drugs often taken by those with breast cancer, a new study suggests.”

Hope for lung cancer patients as new clinical trial plan launched
A new alliance is to bring fresh hope to lung cancer patients, aiming to enrol every sufferer in a clinical trial in a bid to beat the devastating disease.

London – “The newly-formed Lung Cancer Alliance will unite the country’s leading research organisations and charities in the hopes of saving lives.”

Thomas Memorial to offer early cancer screenings
CHARLESTON, W.Va. – “Thomas Memorial Hospital is starting a new program meant to help diagnose lung cancer or other lung issues more quickly than in the past.”

Comorbidities do not explain lower surgery rates among blacks with NSCLC
“Racial differences in comorbidity do not fully explain why black patients with early-stage non–small cell lung cancer undergo surgery less frequently than white patients, according to study results.”

For Treatment of Extensive-Disease Small-Cell Lung Cancer (ED-SCLC), No Emerging Therapy is Likely to Replace Etoposide/Carboplatin as the Standard of Care Before 2022
“Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the numerous therapies in clinical development for extensive-disease small-cell lung cancer (ED-SCLC), no emerging therapy is likely to replace etoposide (Bristol-Myers Squibb's Etopophos/VePesid, generics)/carboplatin (generics) as the standard of care before 2022. Interviewed experts complain that treatment for SCLC has changed very little in decades, and--given the challenges of treating this aggressive disease and the current clinical pipeline--experts are pessimistic that the treatment landscape will improve in the near future.”

Lung cancer mortality rates linked to primary care provider density
DENVER – “Lung cancer remains the leading cause of cancer-related deaths and is tied as the third leading cause of death overall in industrialized countries. Within the United States, several groups identified by race, sex, and socioeconomic status have been linked to increased cancer mortality, suggesting a disparity because of these characteristics. The relationships are complicated by the fact that many of these characteristics may also be associated with areas of decreased access to care and local resources and not inherently based on implicit biases. Researchers from the University of Washington in Seattle, Washington wanted to know the effect access to care had on lung cancer mortality among blacks and whites in the United States. In a recent study published in the International Association for the Study of Lung Cancer's Journal of Thoracic Oncology (JTO) researchers found lower mortality was associated with higher primary care provider density.”

Week Ending April 21, 2013

New treatment pioneered at Peter Mac boosts lung cancer survival rates
“LUNG cancer patients have been given three times the chance of surviving for more than four years through a new focused treatment pioneered by Melbourne doctors.”

SMH lung cancer patients breathe easier thanks to a Canadian first
“A team of thoracic surgeons at Surrey Memorial Hospital (SMH) are diagnosing and treating lung cancer earlier, faster, with fewer tests and ultimately saving lives through a pilot program that is a first for Canada and possibly even North America.”

St. Vincent's students raise money to fight lung cancer
“St. Vincent’s Academy students, through their second annual White the Night event, raised nearly $2,000 to help in an exercise program for lung cancer patients. Students at St. Vincent’s played a fundraising basketball game against Long County to raise money for the cause through all admissions, as well as T-shirt sales and donations.”

PARP inhibitors may beat cisplatin resistance in lung cancer
“People with non-small cell lung cancer (NSCLC) who become resistant to the widely used chemotherapy drug cisplatin may be able to counteract this problem with the use of agents that target the protein poly (ADP-ribose) polymerase 1 (PARP1), investigators have found.”

Early detection is key, but difficult in many cases
LAKE CHARLES, Louisiana (KPLC) — “Early detection of lung cancer is incredibly difficult because most patients do not exhibit obvious symptoms until the disease has progressed. We talk to one lung cancer survivor about what brought him to the emergency room where an early diagnosis potentially saved his life.”

NCI investigators design genetically engineered mouse to study human lung squamous cell carcinoma
“National Cancer Institute (NCI) investigators have designed a genetically engineered mouse for use in the study of human lung squamous cell carcinoma (SCC). SCC is a type of non-small cell lung carcinoma, one of the most common types of lung cancer, with a five-year survival rate of about 15 percent.”

Multicenter study confirms low testosterone in 84 percent of lung cancer patients taking crizotinib
“A previous study by the University of Colorado Cancer Center reported the common side effect of low testosterone in men treated with the recently approved lung cancer agent, crizotinib. A new study published this week in the journal Cancer confirms this finding in a multi-national sample, details the mechanism of reduced testosterone, and provides promising preliminary evidence that widely available hormone replacement therapies can alleviate this side effect in many patients.”

Blood test detecting lung cancer quicker
“It’s a technology that’s helping dramatically reduce lung cancer deaths.”

Week Ending April 14, 2013

Fox Chase Researchers Find Some Lung Cancers Linked to Common Virus
Nearly 6% of lung cancer tissue samples from non-smokers show signs that HPV may have triggered the tumors

“A common virus known to cause cervical and head and neck cancers may also trigger some cases of lung cancer, according to new research presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013 on Wednesday, April 10.”

Scott Wahle performs songs of Nat King Cole and Rosemary Clooney in Quincy cabaret
“When Rosemary Clooney sang the lyrics “Come On-A My House/ I’m Going to Give You Everything,” she turned the song into a hit that expressed an effusive optimism and generosity.”

Lung cancer drug trial underway
NEW HAVEN, Conn. (WTNH) – “A drug trial is underway for an aggressive form of lung cancer. It's at Smilow Cancer Hospital at Yale-New Haven Hospital.”

Big Spread Seen in Lung Cancer False Positives
“Nationwide, one patient in 10 operated on for suspected lung cancer had benign disease, but the false positive rates varied widely from state to state, an analysis showed.”

Week Ending April 7, 2013

Advances in Molecular Testing Offer New Hope for Lung Cancer Patients
Leading Health Care Organizations Issue Guideline Recommendations for Molecular Testing and Targeted Therapies

“The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad. Now, for the first time after a decade of biomarker testing in lung cancer, a uniform approach for testing for the EGFR mutation and ALK rearrangement along with the availability of targeted therapies offer lung cancer patients the chance for improved quality of life and more time with their loved ones.”

AACR: Lung Cancer Therapy Innovations
“Today, ahead of the American Association for Cancer Research Annual Meeting, held this year April 6–10 in Washington, DC, we speak with Dr. Julie Brahmer, associate professor of oncology at Johns Hopkins School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, about lung cancer therapy.”

Researchers Uncover a Genetic Vulnerability of Lung Cancer to Lay the Foundation for New Drug Options
“Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells -- a specific genetic weakness that can be exploited for new therapies.”

Novel Serum Biomarker Bilirubin Predicted Lung Cancer Risk in Smokers
WASHINGTON, D.C. — “Smokers with low bilirubin levels were at increased risk for lung cancer incidence and mortality compared with those who had the highest bilirubin levels, making serum bilirubin a potential biomarker for lung cancer risk prediction, according to data presented at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10.”

Video-assisted Surgery for Lung Cancer
“Surgeons at Beth Israel Deaconess Medical Center are now offering lung cancer patients a new option in minimally invasive surgery, using a robot to assist them removing cancerous lobes.”

Region's first high-risk screening program for lung cancer available at UC Cancer Institute
CINCINNATI – “Lung cancer is the number one killer in the United States, and the Tri-State has a higher-than-average rate of the disease.”

South Shore Hospital Offers Lung Cancer Screenings for High-Risk Patients
Lung cancer screenings using low-radiation CT technology are now being offered at South Shore Hospital in Weymouth.

“Patients at high risk of lung cancer may be eligible for a using low-radiation CT (computed tomography) technology at South Shore Hospital’s Diagnostic Imaging and Dana-Farber/Brigham and Women’s Cancer Center.”

March

Week Ending March 31, 2013

Lung cancer study takes page from Google's Playbook news
“Mathematical model that allows the Google search engine to rank webpages also offers insight into how lung cancer spreads. The same sort of mathematical model used to predict which websites people are most apt to visit is now showing promise in helping map how lung cancer spreads in the human body, according to a new study published in the journal Cancer Research.”

Number of US cancer survivors is on the rise
“The number of Americans who have survived cancer is on the rise and is expected to reach 18 million people in the next decade, according to a report released Wednesday.”

Smoking Immediately Upon Waking May Increase Risk of Lung and Oral Cancer
(HealthNewsDigest.com) - UNIVERSITY PARK, Pa. – “The sooner a person smokes a cigarette upon waking in the morning, the more likely he or she is to acquire lung or oral cancer, according to Penn State researchers.”

Many doctors do not provide tobacco cessation assistance to lung cancer patients
Cancer Physicians who care for lung cancer patients recognize the importance of tobacco cessation, but often do not provide cessation assistance to their patients according to a recent study published in the Journal of Thoracic Oncology (JTO).

“An online survey was conducted in 2012 by the International Association for the Study of Lung Cancer's (IASLC) Tobacco Control and Smoking Cessation Committee. The survey asked IASLC members about their practices, perceptions and barriers to tobacco assessment and cessation in cancer patients. More than 1,500 IASLC members responded and more than 90 percent of the physician respondents believe that active current smoking affects treatment outcomes and that tobacco cessation should be a standard part of clinical care.”

Pfizer lung cancer pill rejected by NICE
(Reuters) – “Pfizer's new lung cancer pill Xalkori is too expensive to be worth using on Britain's state health service, the country's health cost watchdog said on Wednesday.”

Week Ending March 24, 2013

Pfizer Grant to be a Game Changer for Lung Cancer Patients
“A lung cancer diagnosis is often considered a death sentence because of its usually poor prognosis and the high visibility of ABC anchorman Peter Jennings’s death from the disease. Symptoms usually present during the later stages of lung cancer. Approximately 85 percent of all lung cancers are non-small cell lung cancer (NSCLC).”

Soybean Meal Peptides Could Stop Colon, Liver And Lung Cancer Growth
“The bean used to make tofu could also have powerful anti-cancer properties, according to a new study published in the journal Food Research International.”

Researchers identify a new approach for treating brain metastases associated with lung cancer
“Lung cancer is the world's most common cause of death from cancer. In Austria, around 4,000 people develop this type of cancer every year. One particular problem is the development of brain metastases in association with the lung tumour. Until now - other than surgery or radiotherapy - there have not been any treatment options available. Now, however, researchers at the MedUni Vienna have identified a possible new approach for treatment.”

Study Aims to Find Better Detection Techniques for Lung Cancer
“Lung cancer afflicts hundreds of thousands of people per year, and early screening and detection can be extremely vital in fighting the disease. According to the National Cancer Institute at the National Institutes of Health, the estimates of new lung cancer cases and deaths are 228,190 and 159,480 respectively for the upcoming year. Most of these deaths can be attributed to late stage cancers that were not detected early on. When lung cancer is found early, the survival rate is roughly 50 percent. However, according to a new study, the current screening tests and techniques are not good at effectively finding lung cancer until it is too late, which is why the study tested the effectiveness of a new technique.”

PLCO criteria catch more lung cancers
“Modified criteria for screening current or former smokers for lung cancer appeared to be more accurate than currently recommended criteria.”

St. Louis CyberKnife Completes First Quarter of Operations, Offers Lung Cancer Patients Alternative Treatment Option
Missouri-based cancer treatment center reports first-quarter treatment numbers for lung cancer.

“Since opening in the fall of 2012, St. Louis CyberKnife has offered an advanced cancer treatment option to help patients facing a disease responsible for more deaths annually than breast, colon and pancreatic cancers combined—lung cancer.”

Studies examine potential links between coal and cancer in Eastern Kentucky
“What do toenails have to with human health and the environment? Like hair, they can contain contaminants that our bodies are shedding.”

Week Ending March 17, 2013

Novartis lung cancer drug gets key FDA designation
“Novartis AG said Friday that its experimental cancer drug LDK378 was designated as a breakthrough therapy by the Food and Drug Administration.”

High Tech Approach To Treat Lung Cancer
“Surgeons at Beth Israel Deaconess Medical Center are now offering lung cancer patients a new option in minimally invasive surgery, using a robot to assist them with removing cancerous lobes.”

Study focuses on potential lung cancer therapies
HUNTINGTON, W.Va.- “Scientists from Marshall University, along with colleagues at Alderson-Broaddus College in Philippi, have completed a study that may eventually help lead to the development of new treatments for lung cancer.”

Medical Corner: Early Detection Could Stop Lung Cancer in Its Tracks
“Lung cancer is the leading cause of cancer death in the US. In fact, more people die of lung cancer than of colon, breast and prostate cancers combined.”

Orange Regional offers lung-cancer screenings Friday
TOWN OF WALLKILL — “Orange Regional Medical Center will offer a screening program to evaluate for early signs of lung cancer, by appointment, on Friday at the Goshen Patient Service Center, 70 Hatfield Lane, Goshen.”

Blood test could cut down on tests for lung cancer
Durham, N.C. — “Routine chest X-rays often end up with patients getting more tests for the possibility of lung cancer.”

Week Ending March 10, 2013

Fitness: Fighting lung cancer
“If there’s one thing Hal Storck discovered through his battle with lung cancer, it’s that it helps to keep moving.”

Lung Cancer CT Screening
Alabama – “Purpose of the test: UAB Hospital is now offering lung cancer screening using low-radiation CT (computed tomography) technology. Research shows a clear benefit for CT lung-cancer screening among individuals who meet strict criteria.”

Dr. Frank Bures: Studies explore relationship between radon, lung cancer
“Radon is the radioactive gas that forms as a decay product of radium, a radioactive mineral. Radium, in turn, comes from the decay of uranium. Both are ubiquitously present throughout the Earth’s crust.”

Lung Cancer Cure? Gene Therapy Eradicates Tumors in Mice
“Lung cancer was cured in mice that had up to 200 tumors, with a gene therapy that blocked the production of a protein that drives tumor development.”

Lung cancer deaths spur legislation for radon testing
“Radon is a radioactive gas that is odorless, tasteless and invisible. The gas is emitted into the air naturally from the soil. It can collect in high concentrations in the air in basements and is blamed for an estimated 700 lung cancer deaths each year in Minnesota, according to a nuclear physicist who testified before the House Housing Finance and Policy Committee on Wednesday.”

Week Ending March 3, 2013

UVA Doctors Using New Lung Cancer Research Method
“Doctors at the University of Virginia Health System are using a new approach to treat lung cancer.

For decades, doctors have treated the cancer with a "one-size-fits-all" approach - by viewing tumors under the lens of a microscope.”

New lung cancer treatment trial launching at Yale-New Haven Hospital
NEW HAVEN — “A new cancer treatment that acts like a nuclear-tipped missile aimed straight at tumor cells could be a breakthrough in treating a deadly form of lung cancer.”

Cancer center offers early test for lung cancer
SIOUX CITY | “Lung cancer can now be detected in current and former smokers earlier and treated sooner with a new testing program being offered by the June E. Nylen Cancer Center.”

Hamilton doctor gets grant to work on lung cancer therapy
“The Canadian Cancer Society has awarded a $1.2 million grant to a Hamilton doctor for his work on radiation therapy for people with inoperable early-stage lung cancer.”

Faster approval for new cancer drugs saving lives
“Michael Weitz was out of options. The Californian had endured chemotherapy, radiation and surgery but his lung cancer still spread to his bones and brain.”

Lung cancer screening could avert 12,000 deaths each year in the US
“Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers has the potential to avert approximately 12,000 lung cancer deaths each year in the United States. That is the conclusion of a new analysis published early online in CANCER, a peer-reviewed journal of the American Cancer Society. By providing a national estimate of potentially avertable lung cancer deaths, the study will help policy makers better understand the possible benefits of LDCT lung cancer screening.”

February

Week Ending February 17, 2013

Marijuana smoking and the risks of lung cancer: time for pause
“While smoking marijuana may have recently been legalized, one shouldn’t conclude that it is necessarily healthy.

For individuals who treat lung cancer patients in the states of Washington and Colorado, the recently passed legislations raise serious concerns. Ironically, this happened on the eve of the 50th anniversary of the first US Surgeon General Report by Dr. Luther Terry in January 1964, which concluded that lung cancer is causally related to cigarette smoking. This report had followed decades of warnings by so-called common sense alarmists who had identified this as a major public health issue but who lacked the data to fully support their claims.”

Study helps define role of early palliative services in lung cancer
“Addressing symptoms and coping were found to be the most prevalent components of early ambulatory palliative care clinic visits in recent research focusing on the emerging practice of early ambulatory palliative care.”

IKBKE gene plays a key role in tobacco-induced lung cancer
“Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response.”

Low-dose CT scans may detect lung cancer sooner
FRESNO, Calif. (KFSN) – “Lung cancer patients often have a grim outlook after diagnosis but technology is helping doctors find possible problems sooner.”

Study: Lung cancer 'to surpass breast cancer' in European women
“A new study released Wednesday found that lung cancer will surpass breast cancer as the top cause of cancer deaths in European women.”

COPD failed to provide independent risk factor for lung cancer
“Previous correlations between chronic obstructive pulmonary disease and lung cancer were due largely to smoking and ascertainment bias; therefore, chronic obstructive pulmonary disease did not represent an independent risk factor for lung cancer, according to results of a matched case-control study.”

IBM's Watson joins doctors in fighting lung cancer with cloud-based medical app
“IBM's Watson will soon be another resource available to doctors in the fight against lung cancer. IBM announced today that, so far, Watson's artificial mind has been filled with over 600,000 pieces of medical evidence. Watson has also ingested over two million pages of text from medical journals and clinical trials. All told, IBM's cognitive computing system is capable of sifting through more than 1.5 million patient records (spanning several decades) as it researches the best treatments for a given patient. Obviously when it comes to cancer, Watson aims to help physicians pinpoint the option most likely to prove successful.”

Poorer patients with lung cancer less likely to receive treatment than wealthier patients
“Poorer lung cancer patients in the developed world are significantly less likely to receive treatment than richer patients, researchers from Newcastle University have found. This inequality in treatment may contribute to the higher death rates for lung cancer in poorer patients.”

Veteran skier prepares for 28th Vasa after lung cancer diagnosis
GRAND TRAVERSE – “Nothing will stop John Bruder from skiing. The North American Vasa is having its Festival of Races this weekend at Timber Ridge Resort and Bruder is going to be a part of it despite the challenges of dealing with lung cancer.”

Breakthrough Test For Lung Cancer At LewisGale Medical Center
“It is not very often that there's a new breakthrough in cancer treatment. But now there is. It's a new tool that can detect lung cancer early enough that it can be treated. The American Cancer Society is recommending all heavy smokers and former heavy smokers 55 and older get the test. It's a low dose CT scan and it's now being offered at LewisGale Medical Center.”

For Young People With Lung Cancer, Genes Are Important
“Lung cancer happens in people who are young. Sitting at a table at the LUNGevity HOPE Summit last year I was blown away one morning. I was the oldest cancer survivor at the table. Being the oldest wasn't what surprised me (even though I'm not that old.) If I had been among a group of people with leukemia or Hodgkin's lymphoma, or even among other people with breast cancer like myself, I wouldn't have been particularly surprised. But the young people I was sitting with were all lung cancer survivors.”

Medical Edge: Lung Cancer
(ABC 6 NEWS) – “A 12-year veteran of the NFL is tackling a big opponent off the field, lung cancer.”

Week Ending February 10, 2013

IBM's Watson joins doctors in fighting lung cancer with cloud-based medical app
“IBM's Watson will soon be another resource available to doctors in the fight against lung cancer. IBM announced today that, so far, Watson's artificial mind has been filled with over 600,000 pieces of medical evidence. Watson has also ingested over two million pages of text from medical journals and clinical trials. All told, IBM's cognitive computing system is capable of sifting through more than 1.5 million patient records (spanning several decades) as it researches the best treatments for a given patient. Obviously when it comes to cancer, Watson aims to help physicians pinpoint the option most likely to prove successful.”

Poorer patients with lung cancer less likely to receive treatment than wealthier patients
“Poorer lung cancer patients in the developed world are significantly less likely to receive treatment than richer patients, researchers from Newcastle University have found. This inequality in treatment may contribute to the higher death rates for lung cancer in poorer patients.”

Veteran skier prepares for 28th Vasa after lung cancer diagnosis
GRAND TRAVERSE – “Nothing will stop John Bruder from skiing. The North American Vasa is having its Festival of Races this weekend at Timber Ridge Resort and Bruder is going to be a part of it despite the challenges of dealing with lung cancer.”

Breakthrough Test For Lung Cancer At LewisGale Medical Center
“It is not very often that there's a new breakthrough in cancer treatment. But now there is. It's a new tool that can detect lung cancer early enough that it can be treated. The American Cancer Society is recommending all heavy smokers and former heavy smokers 55 and older get the test. It's a low dose CT scan and it's now being offered at LewisGale Medical Center.”

For Young People With Lung Cancer, Genes Are Important
“Lung cancer happens in people who are young. Sitting at a table at the LUNGevity HOPE Summit last year I was blown away one morning. I was the oldest cancer survivor at the table. Being the oldest wasn't what surprised me (even though I'm not that old.) If I had been among a group of people with leukemia or Hodgkin's lymphoma, or even among other people with breast cancer like myself, I wouldn't have been particularly surprised. But the young people I was sitting with were all lung cancer survivors.”

Medical Edge: Lung Cancer
(ABC 6 NEWS) – “A 12-year veteran of the NFL is tackling a big opponent off the field, lung cancer.”

January

Week Ending January 27, 2013

MD Anderson Cancer Center Orlando Ahead of the Game in Lung Cancer Screenings
“One year after MD Anderson Cancer Center Orlando launched a pilot lung cancer screening program for patients most at risk for developing the disease, such screenings are now being recommended by the American Cancer Society. MD Anderson - Orlando was the first in Central Florida to offer this type of lung cancer screening program which targets those most at risk for lung cancer, smokers and former smokers, in the hopes of catching any sign of cancer early, and improving survival rates.”

Women's lung cancer death risk rises
“Female smokers are more likely to die from lung cancer now than a few decades ago, a new study says.”

IU researcher’s lung cancer work may someday improve standard of care
INDIANAPOLIS – “Lung cancer researchers at Indiana University Melvin and Bren Simon Cancer Center are developing new anti-cancer agents that may someday improve the current standard of care.”

EGFR doesn't predict outcomes in lung cancer
“Mutation in the epidermal growth factor receptor (EGFR) gene is not a prognostic factor in persons with non-small cell lung cancer (NSCLC) who have undergone surgical resection or who have received conventional therapies to fight a recurrence, researchers have discovered. However, after disease recurrence, the treatment with EGFR tyrosine kinase inhibitors (TKIs) may prolong survival.”

Drug response marker may speed lung cancer prevention trials
“Changes in the expression of microRNA-34c 6 months after treatment with a medicine to prevent lung cancer correlated with a benefit from the drug that was seen much later.”

Lung Cancer Blood Test Could Be Epic Development
“Epic Sciences received a phase II contract from the SBIR program supported by the National Cancer Institute and the National Institutes of Health. The contract will fund the further development of an assay to identify and characterize circulating tumor cells (CTCs) in lung cancer patients. The results of this contract are expected to provide a basis for the development of new cancer diagnostic products.”

Treatment outcomes compared in early-stage lung cancer
“A retrospective comparison demonstrated that in persons with stage I non-small cell lung cancer (NSCLC), overall survival was superior among patients undergoing lobectomy or pneumonectomy compared with patients undergoing stereotactic body radiation therapy (SBRT), but cancer-specific survival rates were similar between the two groups.”

Valerie Harper Opens Up About Her Battle With Lung Cancer
“Veteran TV actress Valerie Harper has opened up about her secret battle with lung cancer in her new memoir.”

Week Ending January 20, 2013

The Lung Cancer Project studies disease's stigma
“A sign reading "Thank you for not smoking" hung on the front door of her home for years.”

Reduce Lung Cancer Risk in 2013 by Testing Your Home for Radon Gas / Elevated radon levels found in roughly 1 in 15 homes nationwide
WASHINGTON – “As part of National Radon Action Month, the U.S. Environmental Protection Agency (EPA) announced today steps the public can take to test, fix and save a life from dangerous radon gas.”

Low-dose CT scanning available to lung cancer patients at Swedes
“New technology at SwedishAmerican could save more lives, it's the future of lung cancer research joins us with more on the future of lung cancer research and diagnosis in the area.”

Segregation Plays Detrimental Role For Black Lung Cancer Patients
“Lung cancer patients who are black seem more likely to die of the disease than white cancer patients in the U.S., especially those living in segregated counties, according to a new study.”

Palliative radiation use for lung cancer higher than advised
(HealthDay)—“Half of patients with metastatic non-small-cell lung cancer (NSCLC) receive at least one course of palliative radiation therapy (RT), with younger patients and those who received chemotherapy or surgery more likely to receive palliative RT, according to a study published online Jan. 7 in the Journal of Clinical Oncology.”

U.S. cancer death rates fall
“The overall death rate for cancer in the United States has dropped by at least one-fifth over the past two decades, according to new statistics from the American Cancer Society.”

Can Surgery for Inoperable Lung Cancer Make a Difference?
“This title needs a little explanation. Why would someone have an operation for an inoperable lung cancer? Yet it happens "all the time" - or often anyway - when it comes to lung cancer. I'll try to explain.”

Lung Association Announces Educational Workshop for Lung Cancer Patients
(Hauppauge, NY) – “The American Lung Association of the Northeast has announced that is has partnered with the Cancer Support Community and the Stony Brook Lung Cancer Evaluation Center to offer the community a free workshop for people affected by lung cancer. The workshop, Frankly Speaking About Cancer: Lung Cancer – will discuss fundamental information about the most current lung cancer treatments, strategies for symptom/side-effect management and tools for survivorship. Members of the Stony Brook Cancer Center will present this workshop on Wednesday, February 13, 2013, from 7:00 p.m. to 9:00 p.m. at the Stony Brook Cancer Center, 3 Edmund D. Pellegrino Road in Stony Brook.”

Week Ending January 13, 2013

Weighing the Benefits and Risks of Lung Cancer Screening
“This week the American Cancer Society announces its lung cancer screening guidelines. In short, we recommend that health care professionals with access to high-quality lung cancer screening and treatment centers should discuss screening with healthy patients aged 55 years to 74 years who have at least a 30-year history of pack-a-day cigarette smoking and who currently smoke or have quit within the past 15 years. The health care professional and patient should discuss all the known benefits and known harms associated with lung cancer screening.”

Legacy Supports American Cancer Society's New Guidelines for Lung Cancer Screenings
“Today, the American Cancer Society (ACS) published guidelines in CA: A Cancer Journal for Clinicians that endorse screenings as a way to help patients and doctors navigate the potentially devastating diagnosis and treatment of lung cancer. In its guidelines, ACS recommended that clinicians discuss low-dose computed tomography (LDCT) screening with high-risk patients for lung cancer.”

Lahey Clinic Offering Free Lung Cancer Screening for Veterans
Burlington's Director of Veteran Affairs Robert Hogan says veterans are at higher risk for lung cancer, so the screening is available for early detection.

“The Burlington Office of Veterans Services wants to inform Burlington veterans that the Lahey Clinic is offering Free Lung Cancer CT Screenings to eligible, qualified veterans.”

Simple radon test can help prevent lung cancer
FAIRBANKS — “January is National Radon Awareness Month and homeowners in Alaska, especially Fairbanks, are being urged to test their homes for the deadly radioactive gas if they have not done so in the last two years.”

'No one should get lung cancer from radon'
7 of 10 homes in Iowa have enough of the gas to require mitigation systems

“A two-year lung cancer survivor, Gail Orcutt has shared her story many times, with one unexpected detail — she’s never smoked. Her cancer was attributed to prolonged exposure to radon — a colorless, odorless, tasteless radioactive gas produced from the decay of naturally occurring uranium in the soil.”

Common Heart Drug Might Improve Lung Cancer Survival
Beta blockers may slow the spread of the disease, researchers report

(HealthDay News) – “New research suggests that beta blockers, medications that are used to control blood pressure and heart rhythms, may also help lung cancer patients live longer.”

Lung Cancer in a Pregnant Woman - A Story That Exposes Myths and Offers Hope
“Buried amidst the excitement of reports that cancer deaths have again decreased in the United States lies a sobering statistic: Lung cancer in pregnant women is increasing.”

Lung Cancer Led Female Cancer Deaths in 2012
Think fast: Which cancer has the highest female mortality rate?

“Many of us would guess a cancer that predominantly affects women, like breast cancer. It’s a logical choice; close to 40,000 women were projected to pass away from the disease in 2012, and numerous breast cancer awareness events (rightly) keep the disease fresh in our minds.”

New Marker of Drug Response May Speed Pace of Lung Cancer Prevention Trials
“Testing medicines to prevent lung cancer requires treating many thousands of high-risk individuals and then waiting 5, 10 or 15 years to discover which of them develop cancer and which, if any, experience survival benefit from the treatment. A University of Colorado Cancer Center study recently published in the journal Cancer Prevention Research proposes a possible waypoint on the way to benefit, which if validated, could dramatically reduce the number of patients needed and time required to test drugs for lung cancer prevention.”

Week Ending January 6, 2013

It's Official! Lung Cancer Alliance Hails Landmark Victory!
President Obama Signs High Mortality Cancer Bill Into Law
Lung Cancer and Pancreatic Cancers Now Research Priorities

“Just hours before the end of the 112th Congress, constitutional deadline for approval of a bill passed by that Congress, President Barack Obama today signed into law the first legislation requiring comprehensive plans of research action for high mortality cancers, with lung and pancreatic cancers given priority status for expedited attention.”

Time is of the essence when treating lung cancer
If cancer is found before it spreads to lymph nodes, the cure rate is upwards of 75 percent

“If you find a nonsmall cell squamous lung cancer early, before it has invaded the lymph nodes or spread to other organs, the cure rate is upwards of 75%.”

Former NFL linebacker, lung cancer advocate, tours OHSU
PORTLAND, OR (KPTV) - “A former NFL linebacker came to Portland to see how researchers at Oregon Health & Science University are bringing new hope to cancer patients.”

Quality of Lung Cancer Surgery Dependent on Physician Specialty
“Medicine has certainly changed in the last several decades. We now have such an array of physician specialties and subspecialties that it's hard as physicians ourselves to keep the fields straight.”

Lung cancer screenings offered
LYNCHBURG — “A cancer screening program aimed at early detection of lung cancer in current or former heavy smokers is being offered through Central Virginia Imaging, part of Radiology Consultants of Lynchburg.”

Helping smokers quit while they're ahead
Lung Cancer Institute offers Tobacco Quit program, early screening

“Some cigarette smokers wait until they have difficulty breathing or are presented with a bleak diagnosis before they decide to quit.”

Last Updated on Monday, 06 January 2014 20:04
 
Caring Ambassadors
Copyright • 2013
Caring Ambassadors
Site designed by Ferguson Lynch
Caring Ambassadors
P.O. Box 1748
Oregon City, OR 97045
503-632-9032
503-632-9038 (Fax)